WO2011113190A1 - Pharmaceutical composition for treating aids and preparation method thereof - Google Patents

Pharmaceutical composition for treating aids and preparation method thereof Download PDF

Info

Publication number
WO2011113190A1
WO2011113190A1 PCT/CN2010/001968 CN2010001968W WO2011113190A1 WO 2011113190 A1 WO2011113190 A1 WO 2011113190A1 CN 2010001968 W CN2010001968 W CN 2010001968W WO 2011113190 A1 WO2011113190 A1 WO 2011113190A1
Authority
WO
WIPO (PCT)
Prior art keywords
parts
solution
chinese medicine
traditional chinese
medicine composition
Prior art date
Application number
PCT/CN2010/001968
Other languages
French (fr)
Chinese (zh)
Inventor
段荣书
Original Assignee
段颖哲
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 段颖哲 filed Critical 段颖哲
Publication of WO2011113190A1 publication Critical patent/WO2011113190A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Definitions

  • the invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating AIDS, belonging to the field of traditional Chinese medicine. Background technique
  • AIDS is a contagious disease that seriously threatens people's health. Its mortality rate is extremely high. At present, there is no effective vaccine prevention and no cure. It spreads widely and is popular, which not only causes huge economic losses, but also Mission hindering social development has become a social issue of great concern to governments. As China's Ministry of Health, the State Planning Commission, the Ministry of Science and Technology, and the Ministry of Finance jointly formulated the "China Medium- and Long-Term Plan for Prevention and Control of AIDS" (1998-2010): "Prevention and control of AIDS is an urgent, complex and long-term arduous task.
  • HAART can be up to 70% after 4 to 5 years of clinical application, and most patients have greater toxic side effects, resulting in decreased patient compliance, 25% of patients will stop HAART; (3) Limitations of indications: For HIV-infected patients with CD4+T cells >400/ ⁇ 1 and plasma HIVRNA ⁇ 30000, antiviral therapy is not advocated, while untreated patients have a >30% chance of developing AIDS within 3 years; (4) Expensive : Patients with HAART need about 800,000 yuan to 100,000 yuan per year. Currently, they can receive HAART patients at their own expense, with only 400 to 500 people per year. The vast majority of poor AIDS patients in China are in a state of no drug availability.
  • HAART treatment requires lifelong medication, for the purpose of shortening the medication time, the treatment is mostly initiated in the middle and late stages of infection.
  • the immunodeficiency caused by HIV infection is a process of chronic progress of interaction between HIV virus and immune system. In the medium term, progressive destruction of immune tissues occurs. If the immune regulation can be treated in time to protect the infected person's immune system, it may delay the time of HAART treatment and play a good therapeutic role. Therefore, the search for safe and effective immune function, while anti-viral natural drugs have become an important research direction in the prevention and treatment of AIDS. Summary of the invention
  • An object of the present invention is to provide a traditional Chinese medicine composition for treating AIDS, and to provide a preparation method of the traditional Chinese medicine composition and a method for detecting the active ingredient thereof.
  • the object of the present invention is achieved by the following technical solutions.
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa.
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa, 140 parts of Curculigo, 140 parts of nutmeg, 140 parts of yam.
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
  • the traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa, 140 parts of Curculigo, 1 ⁇ part of nutmeg, 140 parts of yam, 140 parts of medlar, 140 parts of Cistanche, and 70 parts of psoralen.
  • the raw materials mentioned above are all Chinese herbal medicines or their processed products.
  • the specific sources are:
  • Luhan For the deer sika deer Cervus nippon Temminck or red deer Cervus elaphus Linnaeus stag The young horns of the ossified hairs.
  • Epimedium Epimedium brevicornum Maxim., Epimedium sagittatum (Sieb. et Zucc.) Maxim. > Epimedium pubescens Maxim., Epimedium wushanense The dry ground part of TS Ying, or Epimedium koreanum Nakai.
  • Cnidium A dry mature fruit of the genus Cnidium monnieri (L.) Cuss.
  • Hawthorn Dry ripe flesh of Cornus officinalis Sieb. et Zucc.
  • Rehmannia glutinosa A freshly processed or dried root of Rehmannia glutinosa Libosch., processed in accordance with the "wine stewing method” or “steaming method” in the Chinese medicine processing method.
  • Curculigo The dried rhizome of the Amaryllidaceae Curculigo orchioides Gaertn.
  • Nutmeg Dried kernels of the nutmeg Myristica fragrans Houtt., used after tanning. .
  • Hazelnut It is a dry ripe fruit of the Solanaceae plant Lycium barbarum L.
  • Cistanche A dried, scaly fleshy stem of the Cistanche deserticola Y. C. Ma or Cistanche tubulosa (Schrenk) Wight.
  • Psoralen A dry mature fruit of the leguminous psoralen Psoralea corylifolia L.
  • the traditional Chinese medicine composition of each aspect of the present invention can be decoctioned by water after the traditional method, or can be processed according to the preparation, and suitable auxiliary materials are added to prepare various clinically required dosage forms, including tablets, granules and capsules.
  • the agent, the pill, the oral liquid, the soft capsule, etc.; the auxiliary material includes a solvent, a disintegrant, a flavoring agent, a preservative, a coloring agent, a binder, a lubricant, and the like.
  • the inventors provide a method of preparation comprising the steps of:
  • step D Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the slag obtained in steps B and C, add water to decoct 2 ⁇ 3 times, each time for 1 ⁇ 2 hours, combine water decoction and The extract of the extract in the step B, the relative density of 1. 25 ⁇ 1. 35, the standby;
  • step E Combine the extracts of steps C and D, vacuum dry, pulverize into dry paste powder, add velvet powder and beta-cyclodextrin inclusion compound of step B, and prepare the desired dosage form, including tablets, granules, Capsules, pills, soft capsules, etc.
  • the inventors provide a method of preparing a tablet, the method comprising the steps of:
  • the traditional Chinese medicine composition of the present invention contains various active ingredients, especially the content of icariin which affects the production The quality of the product. Therefore, in order to detect the content of each active ingredient in the traditional Chinese medicine composition, in particular, the content of icariin, the inventors have also provided a method for detecting an active ingredient, in addition to the conventional test items of pharmacy, The following qualitative identification and content determination methods are included.
  • the content determination method is:
  • Liquid chromatography conditions using 18 ⁇ ⁇ silicon germanium bonded silica as a filler; volume 28: 72 acetonitrile-water mixture as mobile phase; detection wavelength is 270nm ; theoretical plate number according to icariin peak should be calculated Not less than 1500;
  • Preparation of the reference solution accurately weigh the icariin reference substance, add methanol to make a solution containing 0.1 mg per 1 ml, that is;
  • Preparation of the test solution Take the traditional Chinese medicine composition 0. 3g ⁇ 0. 5g, accurately weighed, placed in a conical flask, precision added 25ml of diluted ethanol, weighed, sonicated for 30 minutes, then weighed The weight of the lost weight is made up with dilute ethanol, shaken, filtered through a microporous membrane of 0. 45 ⁇ ⁇ , and the filtrate is taken, that is, obtained;
  • Assay Accurately draw the reference solution and the test solution for each ⁇ ⁇ ⁇ , inject into the liquid chromatograph, measure and calculate the data.
  • the qualitative identification method includes the following items:
  • test solution another take astragaloside reference substance, add methanol to make lmg solution per lml, as a reference solution; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution ⁇ , the reference solution 5 ⁇ 1, respectively Point on the same silica gel G thin-layer plate, a mixture of dichloromethane-methanol-water in a volume ratio of 13:7:2 as a developing solvent, unroll, take out, dry, spray with 10% sulfuric acid ethanol solution, 105 ⁇ Heating to the spot to clear the color; in the chromatogram of the test sample, in the position corresponding to the chromatogram of the reference substance, the spot of the same color is displayed under sunlight;
  • the traditional Chinese medicine composition of each group of the invention has the effects of tonifying the kidney and strengthening the yang, and correcting the poisoning effect, and can be used for treating AIDS and improving various complications. It has been experimentally proved that the traditional Chinese medicine composition of the first embodiment of the present invention can effectively inhibit HIV, protect the immune system of experimental animals, and have an aphrodisiac effect on experimental animals; the traditional Chinese medicine composition of the second embodiment can further improve the constitution and appetite of the model animals. Reducing discomfort such as diarrhea; Chinese medicine combination #1 of Option 3 can comprehensively improve the therapeutic effect, replenish spleen and kidney, lead qi stagnation, and improve the quality of life of model animals and patients.
  • Treatment was started 71 days after 1 ml, and were randomly divided into SIV control group, low dose group and high dose group, with 4 test monkeys in each group.
  • the low-dose group is equivalent to the human clinical therapeutic amount, ie, 0. 338g/Kg;
  • the high-dose group is equivalent to three times the low-dose group, ie, 1.014g/Kg, once a day, continuous administration for 8 weeks. , without interruption in the middle, continue to observe for 8 weeks after stopping the drug.
  • Each was formulated into an aqueous suspension of 100 ml, and administered according to the actual body weight of the monkey.
  • the SIV control group was an untreated group, and the same amount of warm boiled water was administered for 8 weeks.
  • the inhibitory effect of Aifuping tablets on monkey immunodeficiency virus (SIV)-infected monkey model virus The fluctuation of viral load in SIV control group after SIV infection is within a certain range, which is consistent with the natural variation of SIV infection. After the treatment in the low-dose group, the viral load decreased significantly, especially at 8 weeks after stopping the drug, and decreased by 1. 52 log compared with that before the treatment. 1. 34 log o Avoplanin high-dose group except one In addition to the accidental death of monkeys, the viral load of other monkeys also decreased significantly. The treatment group did not show a virus rebound after stopping the drug. Therefore, it can be considered that the experimental results suggest that Avovir tablets have a significant inhibitory effect on the SIV-infected monkey model.
  • the protective effect of Aifuping tablets on the immune system of monkey immunodeficiency virus (SIV) infected monkey model The monkey lymph node biopsy showed that the lymph node structure of the control group gradually deteriorated with the prolongation of the disease course, which is consistent with the SIV infection model.
  • the pathological changes of the natural pathology the high-dose group in the treatment group was examined for lymph node examination, and its structure was slightly worse, but it was significantly better than the control group; the tissue structure of the low-dose group did not deteriorate with the disease course, but stabilized.
  • the direction of development It is suggested that Avopine has a certain protective effect on the immune system, and the low dose group is better than the high dose group.
  • the penile erection time of the rats was recorded after local electrical stimulation. On the 29th day, the rats in each group were sacrificed. The foreskin gland, seminal vesicle, prostate and levator ani muscle were removed, weighed, and the organ index was calculated.
  • Experimental drug 1
  • the drug of the invention as above, is made into a dry powder.
  • 2 positive drugs ⁇ Fuzheng granules (national medicine Zhunzi Z22022497) Jilin Tonghua Shenyuan Pharmaceutical Co., Ltd. production.
  • Cyclosporin A Produced by Swiss Novartis Pharmaceuticals.
  • mice Adult oral Avo Fu Ping dry powder 5. 8 g, is 0. 08319 g dry powder ⁇ kg - 1 body weight.
  • the equivalent dose of the mouse is 0. 754 g dry powder, kg- 1 body weight.
  • the equivalent dose of the mouse drug is used as the low dose; the equivalent dose is twice the medium dose; the equivalent dose is 4 times the high dose.
  • the adult dose of positive drug is 30g per day, which is 0.43g ⁇ kg" 1 body weight.
  • the amount of mice is twice the equivalent dose, that is, 8 g dry powder * kg - 1 body weight. Animals are randomly divided into groups of 12 animals.
  • Lymphocyte subsets detection bleeding in the eyelids of mice, anticoagulation of heparin. 0. lml take anticoagulant and CD: i, CD 4, CD 8 , and CD 19 monoclonal antibody to a fluorescent binding 4 ⁇ incubated for 30 minutes followed by lymphocyte subsets by flow cytometry.
  • the maximum concentration of Aifuping tablets was 2.46g crude drug/ml, and the mice were given 2 times/24h at the maximum concentration of maximum gavage volume (0.8 ml/20g).
  • the cumulative dose was 197g/kg, which is equivalent to clinical adults.
  • the dosage was 477 times (the clinical adult daily dose of 24.78g crude drug / 60 kg), the animal showed no obvious side effects, suggesting that the drug is safe and non-toxic in large doses.
  • Hematological indicators There was no significant difference in the majority of hematology indicators between the groups. The difference between the few doses of the different dose groups and the blank group was statistically significant, but it was basically within the normal range.
  • Blood biochemical indicators There was no significant difference in the blood biochemical indicators of each group. A few different indicators also returned to normal after one month of restorative observation.
  • Decoction 30g Epimedium 120g, Astragalus 120g, Cnidium 120g, Hawthorn 120g, Rehmannia glutinosa 240g - boiled twice, add 10 times the amount of water each time.
  • the decoction is taken orally and served on the same day for 6 months. Viral load is controlled to inhibit water 1Q level, the patient's self-inductive physical strength is significantly enhanced, and the quality of life is significantly improved.
  • the prescription was applied to treat more than 30 cases of AIDS patients, with an effective rate of 92%.
  • Deer antler 45g Epimedium 150g, Astragalus 150g, Cnidium 150g, Hawthorn 150g, Rehmannia glutinosa 300g. Usage: Oral decoction.
  • antler 42g epimedium 140g, astragalus 140g, Cnidium 140g, Hawthorn 140g, Rehmannia 280g.
  • Usage Oral decoction; or powdered antler, combined with water extract concentrate of other APIs, dried, crushed, and packed into capsules.
  • the side has been used to treat more than 70 cases of AIDS patients, with an effective rate of 96%.
  • antler 300g epimedium 1200g, astragalus 1200g, Cnidium 1200g, Hawthorn 1200g, Rehmannia glutinosa 2400g, Curculigo 1200g, Nutmeg 1200g, Yam 1200g.
  • step (2) (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add enough water to cook twice, each time for 1 hour, combine water decoction and steps (2)
  • the obtained aqueous solution is concentrated under reduced pressure to an extract having a relative density of 1.25 to 1.30 at 60 ° C, and used;
  • step (2) (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water to cook for 3 times, add 5 times of water each time, cook for 2 hours, combine with water to cook.
  • the cooking liquid and the aqueous solution obtained in the step (2) are concentrated under reduced pressure to an extract having a relative density of 1.30 to 1.35 at 60 ° C, and used;
  • the ethanol extract is combined, the ethanol is recovered, and the extract having a relative density of 1.30 to 1.32 is concentrated to 6 CTC under reduced pressure, and the extract and the dregs are reserved; (3) Decoction of Rehmannia glutinosa, Epimedium, Astragalus and Chinese yam twice, the first time with 10 times the amount of water for 2 hours, the second time with the step (2) to obtain the dregs, add 8 times the amount Decoction for 1.5 hours, combined with water decoction, concentrated to 6CTC, the relative density of 1.05 ⁇ 1.10 clear paste, high-speed centrifugation, separate the centrate, continue to concentrate under reduced pressure to 6CTC, the relative density is about 1.30 ⁇ 1.32 Extract, spare;
  • step (2) (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water for 3 times, and add 1 time 12 times water for 1.5 hours, 2, 3 Add 8 times the amount of water for 1 hour, combine the water decoction liquid and the aqueous solution obtained in step (2), and concentrate to a concentration of 1.26 ⁇ 1.28 of the extract at 60 ⁇ under reduced pressure, and set aside;
  • antler 450g epimedium 1500g, astragalus 1500g, Cnidium 1500g, Hawthorn 1500g, Rehmannia glutinosa 3000g, Curculigo 1500g, Nutmeg 1500g, Yam 1500g.
  • antler 450g epimedium 1500g, astragalus 1500g, Cnidium 1500g, Hawthorn 1300g, Rehmannia glutinosa 2600g, Curculigo 1300g, nutmeg 1300g, Yam 1300g.
  • step (2) (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water to cook for 3 times, add 5 times of water each time, cook for 2 hours, combine with water to cook.
  • the cooking liquid and the aqueous solution obtained in the step (2) are concentrated under reduced pressure to an extract having a relative density of 1.30 to 1.35 at 60 ° C, and used;
  • step (2) (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add enough water to cook twice, each time for 1 hour, combined with water The immersion of the extract, and the relative density of the granules of 1. 25 ⁇ 1. 30, spare;
  • step (2) (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add water for 3 times, add 5 times of water each time, and cook 2 times.
  • the extract of the extract is used in an amount of 1. 30 ⁇ 1. 35 of the extract;
  • the side was used to treat more than 80 cases of AIDS patients, with an effective rate of 96.2%.
  • Example 18 The prescription: antler 4kg, epimedium 13kg, astragalus 13kg, Cnidium 13kg, hawthorn 13kg, rehmannia root 26kg, curculigo 13kg, nutmeg 13kg, yam 13kg, medlar 13kg, Cistanche 13kg, psoralen 6. 5kg.
  • Extract Hawthorn, Curculigo, Cnidium, and psoralen with 6 times 80% ethanol for 3 times, add 8 times for the first time for 2 hours, and add 2 times for the second and third times for 5 hours. , the extracts of the extracts, the extracts and the dregs of the extracts;
  • step (2) (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add water for 3 times, and add 12 times the amount of water for the first time. 5 ⁇ The immersed in the second and third times, the second and third times, the amount of water was decocted for 1 hour, the water was added to the water and the aqueous solution was condensed to a concentration of 1.26 ⁇ 1. Paste
  • antler 5kg, epimedium 15kg, astragalus 15kg, Cnidium 15kg, hawthorn 15kg, rehmannia root 30kg, curculigo 15kg, nutmeg 15kg, yam 15kg, hazelnut 15kg, Cistanche 15kg, psoralen 7. 5g .
  • antler 4.5kg, epimedium 15kg, astragalus 13kg, Cnidium 13kg, hawthorn 15kg, rehmannia root 30kg, curculigo 15kg, nutmeg 15kg, yam 13kg, medlar 13kg, Cistanche 13kg, psoralen 6.5kg.
  • step (2) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Radix and Chinese yam twice, first time with 10 times water for 2 hours, second time with step (2) (3) Dilute the dregs, add 8 times the amount of water to decoct for 1.5 hours, combine the decoction liquid and the aqueous solution obtained in step (2), concentrate under reduced pressure to a clear density of 1.05 ⁇ 1.10 at 60C, centrifuge at high speed, and separate the centrifugation solution. And continue to concentrate under reduced pressure to 60 ⁇ when the relative density is about 1.30 ⁇ 1.32 of the extract, spare;
  • Example 21 Prescription: antler 4.2g, epimedium 14kg, astragalus 14kg, Cnidium 14kg, hawthorn 14kg, rehmannia root 28kg, curculigo 14kg, nutmeg 14kg, yam 14kg, wolfberry 14kg, Cistanche 14kg, psoralen 7kg.
  • step (2) (4) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Radix and Chinese yam twice, the first time with 12 times the amount of water for 1.5 hours, the second time and step (2) (3) Dilute the dregs, add 8 times the amount of water for 1 hour, combine the decoction liquid and the aqueous solution obtained in step (2), concentrate under reduced pressure to a clear density of 1.05 ⁇ 1.10 at 60 ° C, centrifuge at high speed, and separate. Centrifugal liquid, continue to concentrate under reduced pressure to 60 ° C, the relative density of about 1.28 ⁇ 1.30 of the extract, spare;
  • the side has been used to treat more than 200 cases of AIDS patients, with a total effective rate of 97%.
  • Example 22 Quality inspection of the tablets obtained in Example 21
  • the n-butanol solution was evaporated to dryness on a water bath, and the residue was added with water 10 ml of warming to dissolve, and allowed to cool.
  • the D-101 macroporous adsorption resin column (inner diameter: 1.5 cm, length 12 cm) was eluted with 50 ml of water, and water was discarded.
  • the solution was eluted with 30 ml of 40% ethanol and the eluent was discarded. After eluting with 50 ml of 70% ethanol, the eluate was collected, evaporated to dryness, and the residue was dissolved in methanol (2 ml) to dissolve.
  • Chromatographic conditions and system suitability test octadecyl silicon germanium bonded silica as a filler; acetonitrile-water (28: 72) as mobile phase; detection wavelength is 270 dishes.
  • the number of theoretical plates should be no less than 1500 according to the peak of icariin.
  • Preparation of the reference solution Accurately weigh the appropriate amount of icariin reference substance, add methanol to make a solution containing 0.1 mg per lml, that is.
  • Preparation of the test solution Take 20 pieces of this product, remove the film coat, grind finely, take about 0. 5g, accurately weighed, set in a conical flask, precision added 25ml of dilute ethanol, weighed, sonicated (power: 240W, frequency: 45kHz) 30 minutes, weigh the weight, make up the lost weight with dilute ethanol, shake well, filter with microporous membrane (0. 45 ⁇ ⁇ ), take the filtrate, get .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • AIDS & HIV (AREA)

Abstract

A pharmaceutical composition for treating AIDS, preparation method, test method and use thereof, said pharmaceutical composition is prepared by the raw materials of Rhizoma Dioscoreae, Rhizoma Curculiginis, Fructus Lycii, Radix Rehmanniae, Radix rehmanniae Preparata preparatum, Herba Cistanches, Fructus Psoraleae, Radix Astragali, Fructus Corni, Herba Epimedii, Fructus Cnidii, Semen Myristicae, Cornu Cervi Pantotrichum etc.

Description

治疗艾滋病的药物组合物及其制备方法 技术领域  Pharmaceutical composition for treating AIDS and preparation method thereof
本发明涉及一种中药组合物, 尤其是一种用于治疗艾滋病的中药组合物, 属于中药领域。 背景技术  The invention relates to a traditional Chinese medicine composition, in particular to a traditional Chinese medicine composition for treating AIDS, belonging to the field of traditional Chinese medicine. Background technique
艾滋病 (AIDS) 是一种严重威胁人们健康的传染性疾病, 其病死率极高, 目前既无有效 疫苗预防, 又无治愈的药物, 并且传播广泛, 流行迅速, 不但造成巨大的经济损失, 还严重 阻碍社会发展, 己成为各国政府十分关注的社会问题。 正如我国卫生部、 国家计委、 科技部、 财政部联合制订的 《中国预防与控制艾滋病中长期规划》 (1998-2010)所说: "预防与控制艾 滋病是一项刻不容缓、 复杂而长期的艰巨任务", 并且认为目前"缺少有效的艾滋病、 性病防 治经验和方法, 大多数医疗卫生机构的医护人员尚不能提供规范的艾滋病、 性病诊疗服务。 " 提出要加速艾滋病治疗药物的研究, 力争有一部分项目达到同期国际先进水平, 并且有一部 分成果用于防治实践。 因此探索中医药防治疗艾滋病的有效方法和药物, 具有重要的现实意 义。  AIDS is a contagious disease that seriously threatens people's health. Its mortality rate is extremely high. At present, there is no effective vaccine prevention and no cure. It spreads widely and is popular, which not only causes huge economic losses, but also Seriously hindering social development has become a social issue of great concern to governments. As China's Ministry of Health, the State Planning Commission, the Ministry of Science and Technology, and the Ministry of Finance jointly formulated the "China Medium- and Long-Term Plan for Prevention and Control of AIDS" (1998-2010): "Prevention and control of AIDS is an urgent, complex and long-term arduous task. The task ", and believe that the current lack of effective AIDS, STD prevention and treatment experience and methods, most medical and health care institutions are still unable to provide standardized AIDS, STD treatment services." Proposed to accelerate the research on AIDS treatment drugs, strive to have a part The project reached the international advanced level in the same period, and some of the results were used for prevention and treatment. Therefore, exploring effective methods and drugs for the prevention and treatment of AIDS by Chinese medicine has important practical significance.
目前 AIDS的防治暂无特异性疫苗,高效抗逆转录病毒治疗(简称 HAART)是目前 AIDS 治疗的主要方法。 合理的抗病毒治疗对抑制 HIV病毒的复制, 提高患者的生活质量和存活率 有一定作用。 但西医抗病毒治疗存在以下问题: (1 ) 不能从根本上消除 HIV, 即使 HIV被长 期抑制至血浆中不可检测的水平, HIV仍在低水平地复制; (2 ) HIV的抗药性及药物的不良 反应: HAART临床应用 4~5年后耐药性可高达 70%, 同时由于大多数化疗药物有较大的毒 副作用, 导致患者的依从性下降, 25%的患者会停止 HAART; (3 ) 适应症局限: 对 CD4+T 细胞 >400/μ1, 血浆 HIVRNA < 30000的 HIV感染者, 不主张抗病毒治疗, 而未经治疗者 3 年内发展至 AIDS的机率 >30%; (4) 价格昂贵: 用 HAART的患者每年需要约 8~10万元, 目前能够自费接受 HAART的患者, 每年仅 400〜500人, 我国绝大多数贫困的艾滋病患者处 于无药可用的状态。  At present, there is no specific vaccine for the prevention and treatment of AIDS, and high-efficiency antiretroviral therapy (HAART) is currently the main method of AIDS treatment. Reasonable antiviral therapy has a certain effect on inhibiting HIV replication and improving patients' quality of life and survival. However, Western medicine antiviral treatment has the following problems: (1) It cannot completely eliminate HIV. Even if HIV is inhibited to an undetectable level in plasma for a long time, HIV is still replicating at a low level; (2) HIV resistance and drug resistance Adverse reactions: HAART can be up to 70% after 4 to 5 years of clinical application, and most patients have greater toxic side effects, resulting in decreased patient compliance, 25% of patients will stop HAART; (3) Limitations of indications: For HIV-infected patients with CD4+T cells >400/μ1 and plasma HIVRNA <30000, antiviral therapy is not advocated, while untreated patients have a >30% chance of developing AIDS within 3 years; (4) Expensive : Patients with HAART need about 800,000 yuan to 100,000 yuan per year. Currently, they can receive HAART patients at their own expense, with only 400 to 500 people per year. The vast majority of poor AIDS patients in China are in a state of no drug availability.
由于 HAART治疗需终身服药, 出于缩短用药时间考虑, 治疗多是感染中后期幵始, 而 事实上, HIV感染所形成的免疫缺陷是一个 HIV病毒和免疫系统互相作用的慢性进展的过程, 早、 中期即出现免疫组织的进行性破坏。 如果能及时进行免疫调节等方面的治疗, 保护感染 者的免疫系统, 有可能大大推迟进行 HAART治疗的时间, 起到良好的治疗作用。 因此, 寻 找具有安全有效的调节免疫功能, 同时又有抗病毒的天然药物已成为防治 AIDS 的重要研究 方向。 发明内容 Because HAART treatment requires lifelong medication, for the purpose of shortening the medication time, the treatment is mostly initiated in the middle and late stages of infection. In fact, the immunodeficiency caused by HIV infection is a process of chronic progress of interaction between HIV virus and immune system. In the medium term, progressive destruction of immune tissues occurs. If the immune regulation can be treated in time to protect the infected person's immune system, it may delay the time of HAART treatment and play a good therapeutic role. Therefore, the search for safe and effective immune function, while anti-viral natural drugs have become an important research direction in the prevention and treatment of AIDS. Summary of the invention
本发明的目的是提供一种用于治疗艾滋病的中药组合物, 同时提供该中药组合物的制备 方法及其有效成分的检测方法。 本发明目的是通过如下技术方案实现的。  SUMMARY OF THE INVENTION An object of the present invention is to provide a traditional Chinese medicine composition for treating AIDS, and to provide a preparation method of the traditional Chinese medicine composition and a method for detecting the active ingredient thereof. The object of the present invention is achieved by the following technical solutions.
方案 1 :  plan 1 :
本发明所述的用于治疗艾滋病的中药组合物, 其有效成分是由如下重量份的原料药制成 的:  The traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160.份、 蛇床子 120〜160份、 山茱萸 Deer antler 30~50 parts, Epimedium 120~160 parts, Astragalus 120~160. Parts, Cnidium 120~160 parts, Hawthorn
120〜160份、 熟地黄 240〜330份。 120~160 parts, Rehmannia glutinosa 240~330 parts.
本发明所述的用于治疗艾滋病的中药组合物, 是优选如下重量份的原料药制成的: 鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 The traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
130〜150份、 熟地黄 260〜300份。 130~150 parts, Rehmannia glutinosa 260~300 parts.
本发明所述的用于治疗艾滋病的中药组合物, 是更优选如下重量份的原料药制成的: 鹿茸 42份、 淫羊藿 140份、 黄芪 140份、 蛇床子 140份、 山茱萸 140份、 熟地黄 280 份。  The traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa.
方案 2:  Scenario 2:
本发明所述的用于治疗艾滋病的中药组合物, 其有效成分是由如下重量份的原料药制成 的:  The traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160份、 蛇床子 120〜160份、 山茱萸 120〜160份、 熟地黄 240〜330份、 仙茅 120〜160份、 肉豆蔻 120〜160份、 山药 120〜160 份。  30~50 parts of velvet antler, 120~160 parts of Epimedium, 120~160 parts of Astragalus, 120~160 parts of Cnidium, 120~160 parts of Hawthorn, 240~330 parts of Rehmannia glutinosa, 120~160 parts of C. chinensis, Nutmeg 120 ~160 servings, yam 120~160 servings.
本发明所述的用于治疗艾滋病的中药组合物, 是优选如下重量份的原料药制成的: 鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 The traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
130〜150份、 熟地黄 260〜300份、 仙茅 130〜150份、 肉豆蔻 130〜150份、 山药 130〜150 份。 130~150 parts, 260~300 parts of Rehmannia glutinosa, 130~150 parts of Curculigo, 130~150 parts of nutmeg, 130~150 parts of yam.
本发明所述的用于治疗艾滋病的中药组合物, 是更优选如下重量份的原料药制成的: 鹿茸 42份、 淫羊藿 140份、 黄芪 140份、 蛇床子 140份、 山茱萸 140份、 熟地黄 280 份、 仙茅 140份、 肉豆蔻 140份、 山药 140份。  The traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa, 140 parts of Curculigo, 140 parts of nutmeg, 140 parts of yam.
方案 3:  Option 3:
本发明所述的用于治疗艾滋病的中药组合物, 其有效成分是由如下重量份的原料药制成 的:  The traditional Chinese medicine composition for treating AIDS according to the present invention is prepared from the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160份、 蛇床子 120〜160份、 山茱萸 120〜160份、 熟地黄 240〜330份、 仙茅 120〜160份、 肉豆蔻 120〜160份、 山药 120〜160 份、 枸杞子 120〜160份、 肉苁蓉 120〜160份、 补骨脂 55〜85份。 30~50 parts of velvet antler, 120~160 parts of Epimedium, 120~160 parts of Astragalus, 120~160 parts of Cnidium, Hawthorn 120~160 parts, 240~330 parts of Rehmannia glutinosa, 120~160 parts of Curculigo, 120~160 parts of nutmeg, 120~160 parts of Chinese yam, 120~160 parts of medlar, 120~160 parts of Cistanche, 50~160 psyllium 85 copies.
本发明所述的用于治疗艾滋病的中药组合物, 是优选如下重量份的原料药制成的: 鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 The traditional Chinese medicine composition for treating AIDS according to the present invention is preferably made of the following raw materials by weight: 40 to 45 parts of velvet antler, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 Cnidium 150 copies, Hawthorn
130〜150份 熟地黄 260〜300份、 仙茅 130〜150份、 肉豆蔻 130〜150份、 山药 130〜150 份、 枸杞子 130〜150份、 肉苁蓉 130〜150份、 补骨脂 65〜75份。 130~150 parts of radix rehmannia 260~300 parts, curculigo 130~150 parts, nutmeg 130~150 parts, yam 130~150 parts, medlar 130~150 parts, Cistanche 130~150 parts, psoralen 65~75 Share.
本发明所述的用于治疗艾滋病的中药组合物, 是更优选如下重量份的原料药制成的: 鹿茸 42份、 淫羊藿 140份、 黄芪 140份、 蛇床子 140份、 山茱萸 140份、 熟地黄 280 份、仙茅 140份、 肉豆蔻 1^)份、 山药 140份、枸杞子 140份、 肉苁蓉 140份、补骨脂 70份。 上面所述的原料药, 均为中药材或其炮制品, 具体来源为:  The traditional Chinese medicine composition for treating AIDS according to the present invention is more preferably made of the following raw materials by weight: 42 parts of antler, 140 parts of Epimedium, 140 parts of Astragalus, 140 parts of Cnidium, 140 parts of Hawthorn, 280 parts of Rehmannia glutinosa, 140 parts of Curculigo, 1^ part of nutmeg, 140 parts of yam, 140 parts of medlar, 140 parts of Cistanche, and 70 parts of psoralen. The raw materials mentioned above are all Chinese herbal medicines or their processed products. The specific sources are:
鹿莺: 为鹿科动物梅花鹿 Cervus nippon Temminck或马鹿 Cervus elaphus Linnaeus的雄鹿 未骨化密生茸毛的幼角。  Luhan: For the deer sika deer Cervus nippon Temminck or red deer Cervus elaphus Linnaeus stag The young horns of the ossified hairs.
淫羊藿: 为小檗科植物淫羊藿 Epimedium brevicornum Maxim.、 箭叶淫羊藿 Epimedium sagittatum (Sieb. et Zucc. ) Maxim. > 柔毛淫羊藿 Epimedium pubescens Maxim.、 巫山淫 羊藿 Epimedium wushanense T. S. Ying、 或朝鲜淫羊藿 Epimedium koreanum Nakai的干燥地 上部分。  Epimedium: Epimedium brevicornum Maxim., Epimedium sagittatum (Sieb. et Zucc.) Maxim. > Epimedium pubescens Maxim., Epimedium wushanense The dry ground part of TS Ying, or Epimedium koreanum Nakai.
黄 : 为豆禾斗植物蒙古黄"^ Astragalus membranaceus (Fisch. ) Bge. var. mongholicus (Bge. ) Hsiao或膜荚黄丧 Astragalus membranaceus (Fisch. ) Bge.的干燥根。  Yellow: dried roots of Astragalus membranaceus (Fisch.) Bge. for the genus Astragalus membranaceus (Fisch.) Bge. var. mongholicus (Bge.) Hsiao or membranaceus.
蛇床子: 为伞形科植物蛇床 Cnidium monnieri (L. ) Cuss.的干燥成熟果实。  Cnidium: A dry mature fruit of the genus Cnidium monnieri (L.) Cuss.
山茱萸: 为山茱萸科植物山茱萸 Cornus officinalis Sieb. et Zucc. 的干燥成熟果肉。 熟地黄: 为玄参科植物地黄 Rehmannia glutinosa Libosch. 的新鲜或干燥块根, 按照中 药炮制方法中的 "酒炖法"或 "蒸法"而制成的炮制加工品。  Hawthorn: Dry ripe flesh of Cornus officinalis Sieb. et Zucc. Rehmannia glutinosa: A freshly processed or dried root of Rehmannia glutinosa Libosch., processed in accordance with the "wine stewing method" or "steaming method" in the Chinese medicine processing method.
仙茅: 为石蒜科植物仙茅 Curculigo orchioides Gaertn. 的干燥根茎。  Curculigo: The dried rhizome of the Amaryllidaceae Curculigo orchioides Gaertn.
肉豆蔻: 为肉豆蔻科植物肉豆蔻 Myristica fragrans Houtt. 的干燥种仁, 经煨制后使 用。 .  Nutmeg: Dried kernels of the nutmeg Myristica fragrans Houtt., used after tanning. .
山药: 为薯蓣科植物薯蓣 Dioscorea opposita Thunb.的千燥根茎。  Yam: The dried roots of Dioscorea opposita Thunb.
枸杞子: 为茄科植物宁夏枸杞 Lycium barbarum L.的干燥成熟果实。  Hazelnut: It is a dry ripe fruit of the Solanaceae plant Lycium barbarum L.
肉苁蓉: 为列当科植物肉苁蓉 Cistanche deserticola Y. C. Ma或管花肉苁蓉 Cistanche tubulosa (Schrenk) Wight的干燥带鳞叶的肉质茎。  Cistanche: A dried, scaly fleshy stem of the Cistanche deserticola Y. C. Ma or Cistanche tubulosa (Schrenk) Wight.
补骨脂: 为豆科植物补骨脂 Psoralea corylifolia L. 的干燥成熟果实。 本发明所述各方案的中药组合物可按传统方法水煎煮后服用煎液,也可按进行制剂加工, 加入适宜的辅料制成多种临床所需剂型, 包括片剂、 颗粒剂、 胶囊剂、 丸剂、 口服液、 软胶 囊等; 所述的辅料包括溶剂、 崩解剂、 矫味剂、 防腐剂、 着色剂、 粘合剂、 润滑剂等。 Psoralen: A dry mature fruit of the leguminous psoralen Psoralea corylifolia L. The traditional Chinese medicine composition of each aspect of the present invention can be decoctioned by water after the traditional method, or can be processed according to the preparation, and suitable auxiliary materials are added to prepare various clinically required dosage forms, including tablets, granules and capsules. The agent, the pill, the oral liquid, the soft capsule, etc.; the auxiliary material includes a solvent, a disintegrant, a flavoring agent, a preservative, a coloring agent, a binder, a lubricant, and the like.
对于口服固体剂型, 发明人提供了一种制备方法, 该方法包括如下步骤:  For oral solid dosage forms, the inventors provide a method of preparation comprising the steps of:
A、 取上述原料药, 将鹿茸粉碎成细粉, 备用;  A. Take the above-mentioned raw materials, crush the velvet antler into fine powder, and set aside;
B、 将肉豆蔻加水蒸馏, 收集挥发油并用足量倍他环糊精包合, 所得包合物备用; 蒸馏后 的水溶液及药渣另置备用;  B. Distilling the nutmeg with water, collecting the volatile oil and encapsulating it with a sufficient amount of cyclodextrin, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved for use;
C、将山茱萸、仙茅、蛇床子、补骨脂加 60%〜90 %乙醇回流提取 2〜3次, 每次提取 1〜 2小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1. 25〜1. 35的浸膏, 浸 膏和药渣备用;  C. Hawthorn, Curculigo, Cnidium, psoralen and 60%~90% ethanol are refluxed for 2~3 times, each time for 1~2 hours, combined with ethanol extract, ethanol is recovered, concentrated to 60° under reduced pressure. C, the relative density of 1. 25~1. 35 of the extract, extract and dregs spare;
D、 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药和步骤 B、 C所得药渣合并, 加水 煎煮 2〜3次, 每次 1〜2个小时, 合并水煎煮液以及步骤 B所得水溶液, 减压浓缩至 60°C时 相对密度为 1. 25〜1. 35的浸膏, 备用;  D. Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the slag obtained in steps B and C, add water to decoct 2~3 times, each time for 1~2 hours, combine water decoction and The extract of the extract in the step B, the relative density of 1. 25~1. 35, the standby;
E、 将步骤 C与 D的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤 B的倍他环 糊精包合物, 制成所需剂型, 包括片剂、 颗粒剂、 胶囊剂、 丸剂、 软胶囊等。  E. Combine the extracts of steps C and D, vacuum dry, pulverize into dry paste powder, add velvet powder and beta-cyclodextrin inclusion compound of step B, and prepare the desired dosage form, including tablets, granules, Capsules, pills, soft capsules, etc.
具体地讲, 发明人提供了一种片剂的制备方法, 该方法包括如下步骤:  Specifically, the inventors provide a method of preparing a tablet, the method comprising the steps of:
A、 取原料药, 将鹿茸粉碎成细粉, 备用;  A. Take the raw material medicine, crush the velvet antler into fine powder, and set aside;
B、 将肉豆蔻加 6倍量水蒸馏 5小时, 收集挥发油, 所得挥发油用 6倍量的倍他环糊精包 合, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  B. Distilling the nutmeg with 6 times the amount of water for 5 hours, collecting the volatile oil, and the obtained volatile oil is wrapped with 6 times the amount of betacyclodextrin, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved for use;
C、将山茱萸、仙茅、蛇床子、补骨脂粉碎成粗粉,加 80 %乙醇回流提取 2次,每次加 5〜 6倍量, 提取 1. 5〜2小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1. 30 的浸膏, 浸膏和药渣备用;  C, the extract of hawthorn, curculigo, Cnidium, psoralen into a coarse powder, adding 80% ethanol reflux extraction 2 times, each time adding 5 to 6 times the amount, extracting 1. 5~2 hours, combined with ethanol extract, The ethanol is recovered, and the extract having a relative density of 1.30 is concentrated at 60 ° C under reduced pressure, and the extract and the dregs are reserved;
D、 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子和山药加水煎煮 2次, 第 1次加 10倍量 水煎煮 2小时, 第二次与步骤 B、 C所得药渣合并, 加 8倍量水煎煮 1. 5小时, 合并水煎煮液 以及步骤 B所得水溶液, 减压浓缩至 60Ό时相对密度为 1. 05〜1. 10的清膏, 高速离心, 分 取离心液, 继续减压浓缩至 60Ό时相对密度约为 1. 30的浸膏, 备用;  D. Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia and Chinese yam twice, the first time with 10 times the amount of water for 2 hours, the second time with the steps B, C obtained dregs, 5的溶液, The high-temperature centrifugation, the centrifugation of the centrifugation solution is carried out by adding 8 times the amount of water to the boiling water for 1. 5 hours, and the aqueous solution obtained by the step B is concentrated to a concentration of 1. 05~1. , the extract having a relative density of about 1.30, which is further concentrated under reduced pressure to 60 Torr, is reserved;
E、 将步骤 C与 D的浸膏合并, 真空千燥, 粉碎成干膏粉, 加入鹿茸粉、 步骤 B的倍他环 糊精包合物及制剂所需辅料, 压制成片剂。 本发明中药组合物中, 含有多种有效成分, 尤其是其中淫羊藿苷含量的多少将影响该产 品的质量。 因而, 为了检测本发明中药组合物中的各有效成分, 尤其是淫羊藿苷的含量, 发 明人还提供了一套有效成分的检测方法, 该方法中除药剂学的常规检测项目外, 还包括如下 的定性鉴别和含量测定方法。 E. Combine the extracts of steps C and D, vacuum dry, pulverize into dry paste powder, add antler powder, the beta-cyclodextrin inclusion compound of step B and the auxiliary materials required for preparation, and compress into tablets. The traditional Chinese medicine composition of the present invention contains various active ingredients, especially the content of icariin which affects the production The quality of the product. Therefore, in order to detect the content of each active ingredient in the traditional Chinese medicine composition, in particular, the content of icariin, the inventors have also provided a method for detecting an active ingredient, in addition to the conventional test items of pharmacy, The following qualitative identification and content determination methods are included.
其中, 含量测定方法为:  Among them, the content determination method is:
液相色谱条件: 用十八垸基硅垸键合硅胶为填充剂; 体积为 28: 72的乙腈 -水混合液为 流动相; 检测波长为 270nm; 理论板数按淫羊藿苷峰计算应不低于 1500; Liquid chromatography conditions: using 18 垸 垸 silicon germanium bonded silica as a filler; volume 28: 72 acetonitrile-water mixture as mobile phase; detection wavelength is 270nm ; theoretical plate number according to icariin peak should be calculated Not less than 1500;
对照品溶液的制备: 精密称取淫羊藿苷对照品, 加甲醇制成每 1ml 含 0. Img 的溶液, 即得;  Preparation of the reference solution: accurately weigh the icariin reference substance, add methanol to make a solution containing 0.1 mg per 1 ml, that is;
供试品溶液的制备: 取中药组合物 0. 3g〜0. 5g, 精密称定, 置具塞锥形瓶中, 精密加入 稀乙醇 25ml , 称定重量, 超声处理 30分钟, 再称定重量, 用稀乙醇补足减失的重量, 摇匀, 用 0. 45 μ πι的微孔滤膜滤过, 取续滤液, 即得;  Preparation of the test solution: Take the traditional Chinese medicine composition 0. 3g~0. 5g, accurately weighed, placed in a conical flask, precision added 25ml of diluted ethanol, weighed, sonicated for 30 minutes, then weighed The weight of the lost weight is made up with dilute ethanol, shaken, filtered through a microporous membrane of 0. 45 μ πι, and the filtrate is taken, that is, obtained;
测定法: 精密吸取对照品溶液与供试品溶液各 ΙΟ μ Ι , 注入液相色谱仪, 测定, 计算数 据, 即得。  Assay: Accurately draw the reference solution and the test solution for each ΙΟ μ Ι , inject into the liquid chromatograph, measure and calculate the data.
定性鉴别方法包括如下项目:  The qualitative identification method includes the following items:
Α、 取中药组合物少量, 研细, 置显微镜下观察, 可见: 茸毛多碎断; 未骨化骨组织, 近 无色, 具多数不规则的块状突起物, 其间隐约可见条纹;  Α, take a small amount of traditional Chinese medicine composition, grind finely, and observe under the microscope, it can be seen that: the hair is broken and broken; the non-ossified bone tissue, nearly colorless, with most irregular block-like protrusions, with streaks visible in the gap;
• Β、 取中药组合物少量, 研细, 加乙醇 30ml, 超声处理 30分钟, 滤过, 滤液置水浴上蒸 干, 残渣加甲醇 lml使溶解, 作为供试品溶液; 另取 5—羟甲基糠醛对照品, 加乙醇制成每 lml含 0. 5mg的溶液, 作为对照品溶液; 照中国药典薄层色谱法试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 GF254薄层板上, 以体积比为 1 : 1的石油醚-乙酸乙酯混合液为展开 剂, 展开, 取出, 晾干, 置 254nm紫外光灯下检视; 供试品色谱中, 在与对照品色谱相应的 位置上, 显相同颜色的斑点;  • Β, take a small amount of traditional Chinese medicine composition, grind finely, add 30ml of ethanol, sonicate for 30 minutes, filter, and drain the filtrate on a water bath, add 1ml of methanol to dissolve the residue, as a test solution; take 5-hydroxyl Based on the furfural reference substance, add ethanol to make a solution containing 0.5 mg per lml, as a reference solution; according to the Chinese Pharmacopoeia thin layer chromatography test, take 5 μl of each of the above two solutions, respectively, on the same silica gel GF254 thin layer On the plate, a petroleum ether-ethyl acetate mixture with a volume ratio of 1:1 is used as a developing solvent, unrolled, taken out, dried, and placed under a UV light of 254 nm; in the chromatogram of the test product, corresponding to the chromatogram of the reference substance Position on the spot, showing the same color;
C、 取中药组合物少量, 研细, 加乙醚 30ml, 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 残渣加乙醇 lml使溶解, 作为供试品溶液; 另取山茱萸对照药材 0. 5g, 同法制备对照药材溶 液; 照中国药典薄层色谱法试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 20 : 5 : 8 : 0. 2的环己垸一二氯甲烷 -乙酸乙酯-甲酸混合液为展开剂, 展开, 取出, 晾干, 喷以 10%硫酸溶液, 于 105°C烘至斑点显色清晰; 供试品色谱中, 在与对照药材色谱相 应的位置上, 显相同颜色的斑点;  C. Take a small amount of traditional Chinese medicine composition, grind finely, add 30ml of ether, heat and reflux for 20 minutes, let cool, filter, the filtrate is evaporated, and the residue is added with 1ml of ethanol to dissolve, as the test solution; 5g, the same method to prepare the reference drug solution; according to the Chinese Pharmacopoeia thin-layer chromatography test, the above two solutions are taken 5 μ 1, each point on the same silica gel G thin-layer plate, the volume ratio is 20 : 5 : 8 : 0 2 of cyclohexanyl-dichloromethane-ethyl acetate-formic acid mixture as a developing solvent, unrolled, taken out, air-dried, sprayed with 10% sulfuric acid solution, and dried at 105 ° C until the spot color is clear; In the chromatogram, a spot of the same color is displayed at a position corresponding to the chromatogram of the reference drug;
D、 取中药组合物少量, 研细, 加甲醇 50ml, 加热回流 4小时, 过滤, 滤液蒸干, 残渣 加水 20ml搅拌使溶解, 移至分液漏斗中, 分别以 20ral、 15ral、 15ml的水饱和的正丁醇萃取 1次, 合并正丁醇液, 用氨试液洗涤 2次, 每次 30ml, 弃去氨试液; 正丁醇液用正丁醇饱和 o D. Take a small amount of traditional Chinese medicine composition, grind finely, add 50ml of methanol, heat under reflux for 4 hours, filter, and evaporate the filtrate. Add 20 ml of water to the residue to dissolve, transfer to a separatory funnel, and saturate with water of 20ral, 15ral, 15ml respectively. The n-butanol is extracted once, and the n-butanol solution is combined, washed twice with ammonia test solution, 30 ml each time, and the ammonia test solution is discarded; n-butanol solution is saturated with n-butanol o
的水洗涤 3次, 每次 30ml, 弃去水液; 正丁醇液置水浴上蒸干, 残渣加水 10ml温热使溶解, 放冷, 过 D- 101大孔吸附树脂柱, 以水 50ml洗脱, 弃去水液, 再用 30ml的 40%乙醇洗脱, 弃去洗脱液; 继以 50ml的 70%乙醇洗脱, 收集洗脱液, 蒸干, 残渣加甲醇 2ml使溶解, 作为 供试品溶液; 另取黄芪甲苷对照品, 加甲醇制成每 lml含 lmg的溶液, 作为对照品溶液; 照 中国药典薄层色谱法试验, 吸取供试品溶液 Ιθμΐ , 对照品溶液 5μ1, 分别点于同一硅胶 G薄 层板上, 以体积比为 13: 7: 2的二氯甲烷-甲醇-水的混合液为展开剂, 展开, 取出, 晾干, 喷以 10%硫酸乙醇溶液, 105Ό加热至斑点显色清晰; 供试品色谱中, 在与对照品色谱相应 的位置上, 在日光下显相同颜色的斑点; Wash the water 3 times, each time 30ml, discard the water; n-butanol solution is evaporated to dryness in a water bath, add 10ml of water to the residue to dissolve, let cool, pass D-101 macroporous adsorption resin column, wash with water 50ml Dissolve, discard the aqueous solution, elute with 30 ml of 40% ethanol, discard the eluate; elute with 50 ml of 70% ethanol, collect the eluate, evaporate to dryness, add 2 ml of methanol to the residue to dissolve. The test solution; another take astragaloside reference substance, add methanol to make lmg solution per lml, as a reference solution; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution Ιθμΐ, the reference solution 5μ1, respectively Point on the same silica gel G thin-layer plate, a mixture of dichloromethane-methanol-water in a volume ratio of 13:7:2 as a developing solvent, unroll, take out, dry, spray with 10% sulfuric acid ethanol solution, 105Ό Heating to the spot to clear the color; in the chromatogram of the test sample, in the position corresponding to the chromatogram of the reference substance, the spot of the same color is displayed under sunlight;
Ε、 取蛇床子对照药材 0. 5g, 加乙醚 30ml, 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 残渣加乙醇 lml使溶解, 作为对照药材溶液; 照中国药典薄层色谱法试验, 吸取 C项下的供 试品溶液及蛇床子对照药材溶液各 5 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 30 : 1 的甲苯-乙酸乙酯混合液为展开剂, 展开, 取出, 晾干, 置 365nm紫外光灯下检视; 供试品色 谱中, 在与对照药材色谱相应的位置上, 显相同颜色的斑点;  Ε, take the Cnidium medicinal herbs 0. 5g, add ether 30ml, heat reflux for 20 minutes, let cool, filter, the filtrate is evaporated, the residue is added with ethanol 1ml to dissolve, as a reference drug solution; according to Chinese Pharmacopoeia thin layer chromatography test 5 μl of each of the test solution and the Cnidium reference drug solution under C are dispensed on the same silica gel G thin layer plate, and the toluene-ethyl acetate mixture with a volume ratio of 30:1 is used as a developing solvent. , unfolding, taking out, drying, and setting it under 365nm ultraviolet light; in the chromatogram of the test sample, the spot of the same color is displayed at the position corresponding to the chromatogram of the reference drug;
F、 取中药组合物少量, 研细, 加水 35ml, 加热煮沸 15分钟, 放冷, 滤过, 滤液用乙酸 乙酯振摇提取两次, 每次 15ml, 置水浴上蒸干, 残渣加乙酸乙酯 lml使溶解, 作为供试品溶 液; 另取枸杞子对照药材 0. 5g, 同法制备对照药材溶液; 照中国药典薄层色谱法试验, 吸取 供试品溶液、 阴性样品溶液各 10 μ ΐ , 对照药材溶液 2 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 3: 2: 1的乙酸乙酯-二氯甲烷-甲酸混合液为展开剂,展开,取出,晾干,置 365nm 紫外灯下检视; 供试品色谱中, 在与对照药材色谱相应的位置上, 显相同颜色的荧光斑点; F, take a small amount of traditional Chinese medicine composition, grind finely, add water 35ml, heat and boil for 15 minutes, let cool, filter, the filtrate is extracted twice with ethyl acetate, 15ml each time, steamed on a water bath, residue added with acetic acid 1ml of the ester is dissolved, as a test solution; another filbert reference drug 0. 5g, the same method to prepare a reference drug solution; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution, the negative sample solution each 10 μ ΐ 2 μ 1 of the reference drug solution was spotted on the same silica gel G thin layer plate, and the mixture of ethyl acetate-dichloromethane-formic acid in a volume ratio of 3:2:1 was used as a developing solvent, unrolled, taken out, and dried. , under the 365nm UV lamp; in the chromatogram of the test sample, the fluorescent spot of the same color is displayed at the position corresponding to the chromatogram of the reference drug;
G、 取中药组合物少量, 研细, 按 2005年版中国药典规定的挥发油测定法提取挥发油, 自挥发油提取器刻度管上端加入沸程为 30〜60'C的石油醚 lml, 蒸馏 5小时, 分取石油醚液 作为供试品溶液; 另取肉豆蔻对照药材 2g, 同法制备对照药材溶液; 照中国药典薄层色谱法 试验,吸取供试品溶液及对照药材溶液 10 μ 1,分别点于同一硅胶 G薄层板上,以体积比为 1 : 1的石油醚-甲苯为展开剂, 展开, 取出, 晾干, 喷以茴香醛试液, 于 105°C加热至斑点显色 清晰; 供试品色谱中, 在与对照药材色谱相应的位置上, 在日光下显相同颜色的斑点。 本发明各组中药组合物均具有补肾壮阳, 扶正托毒之功效, 可用于治疗艾滋病、 改善各 种并发症状。 经实验证明, 本发明方案 1的中药组合物即可有效抑制艾滋病病毒、 保护实验 动物的免疫系统、 对实验动物具有壮阳的作用; 方案 2的中药组合物可进一步改善模型动物 的体质、 提高食欲、 减少腹泻等不适症状; 方案 3的中药组合 #1可综合提升治疗效果、 补益 脾肾、 行气导滞、 改善模型动物和患者的生存质量。 以下以方案 3中药组合物的动物实验及 η 临床试验效果为例, 说明本发明各组中药组合物 (实验中命名为: 艾伏平片) 的功效。 G. Take a small amount of traditional Chinese medicine composition, and grind it. Extract the volatile oil according to the volatile oil method specified in the 2005 Chinese Pharmacopoeia. Add 1 ml of petroleum ether with a boiling range of 30~60'C from the upper end of the scale tube of the volatile oil extractor, and distill for 5 hours. Take petroleum ether solution as the test solution; take 2g of reference material of the nutmeg, and prepare the reference drug solution by the same method; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution and the reference drug solution 10 μ 1, respectively The same silica gel G thin-layer plate, with a volume ratio of 1:1 petroleum ether-toluene as a developing agent, unrolled, taken out, air-dried, sprayed with anisaldehyde test solution, heated at 105 ° C until the spot color is clear; In the chromatogram of the test sample, spots of the same color are displayed in daylight at a position corresponding to the chromatogram of the reference drug. The traditional Chinese medicine composition of each group of the invention has the effects of tonifying the kidney and strengthening the yang, and correcting the poisoning effect, and can be used for treating AIDS and improving various complications. It has been experimentally proved that the traditional Chinese medicine composition of the first embodiment of the present invention can effectively inhibit HIV, protect the immune system of experimental animals, and have an aphrodisiac effect on experimental animals; the traditional Chinese medicine composition of the second embodiment can further improve the constitution and appetite of the model animals. Reducing discomfort such as diarrhea; Chinese medicine combination #1 of Option 3 can comprehensively improve the therapeutic effect, replenish spleen and kidney, lead qi stagnation, and improve the quality of life of model animals and patients. The following animal experiment of the Chinese medicine composition of the scheme 3 and The effect of the η clinical test effect is exemplified, and the efficacy of each group of the traditional Chinese medicine composition of the present invention (named: Aifuping tablet in the experiment) is illustrated.
实验例 1 : 艾伏平片治疗猴免疫缺陷病毒 (SIV) 感染猴模型的实验研究  Experimental Example 1 : Experimental study of avidin tablets in the treatment of monkey immunodeficiency virus (SIV) infected monkey model
(一) 实验药物: 熟地黄 28kg、 鹿茸 4. 2kg、 山茱萸 14kg、 淫羊藿 14kg、 黄芪 14kg、 蛇床子 14kg,仙茅 14kg,肉苁蓉 14kg,枸杞子 14kg,肉豆蔻 14kg,山药 14kg、补骨脂 7. Okg , 制成片剂。  (1) Experimental drugs: Rehmannia glutinosa 28kg, velvet antler 4. 2kg, hawthorn 14kg, Epimedium 14kg, Astragalus 14kg, Cnidium 14kg, Curculigo 14kg, Cistanche 14kg, Scorpion 14kg, Nutmeg 14kg, Yam 14kg, Bone Lipid 7. Okg, made into tablets.
(二) 实验方法: 采用 SIVmac251感染猴模型, 体内试验评价艾伏平片抗猴免疫缺陷病 毒 (SIV) 的效果。 选取健康雄性恒河猴 (重 3. 5〜6. 5Kg ) 12只, 通过静注感染 SIVmac251 (II) Experimental methods: The monkey model was infected with SIVmac251, and the effect of Aifuping tablets against monkey immunodeficiency virus (SIV) was evaluated in vivo. Select healthy male rhesus monkeys (weight 3. 5~6. 5Kg) 12, infect SIVmac251 by intravenous injection
( 5个 100%猴感染剂量) 1ml后 71天开始治疗, 随机分为 SIV对照组、低剂量组和高剂量组, 每组 4只试验猴。 低剂量组相当于人的临床治疗量, 即 0. 338g/Kg; 高剂量组相当于低剂量 组的 3倍量, 即 1. 014g/Kg, 每日 1次给药, 连续给药 8周, 中间不间断, 停药后继续观察 8 周。 分别配成水溶液混悬剂 100毫升, 按猴实际体重给药。 SIV对照组为不治疗组, 连续 8 周以等量温开水灌胃。 (5 doses of 100% monkey infection) Treatment was started 71 days after 1 ml, and were randomly divided into SIV control group, low dose group and high dose group, with 4 test monkeys in each group. The low-dose group is equivalent to the human clinical therapeutic amount, ie, 0. 338g/Kg; the high-dose group is equivalent to three times the low-dose group, ie, 1.014g/Kg, once a day, continuous administration for 8 weeks. , without interruption in the middle, continue to observe for 8 weeks after stopping the drug. Each was formulated into an aqueous suspension of 100 ml, and administered according to the actual body weight of the monkey. The SIV control group was an untreated group, and the same amount of warm boiled water was administered for 8 weeks.
(三) 实验结果:  (3) Experimental results:
1、艾伏平片对猴免疫缺陷病毒(SIV )感染猴模型症状和体征等的影响: 实验过程中 SIV 感染后各猴的一般情况尚好, 精神好, 食欲一般。 各组治疗前和治疗后淋巴结大小的变化均 属于感染 SIV后的通常反应,组间无显著差异。 SIV对照组中有 1只猴在感染后 80天时死亡。 尸体解剖见: 颌下、 腋窝及腹股沟淋巴结肿大; 锁骨下气管旁淋巴结肿大, 质地变实; 左右 肺叶肿大, 灰红色, 质地变实; 结肠粘膜充血, 水肿, 灶状糜烂。 其它各动物食欲、 精神等 一般, 体重变化差异无显著意义。  1. Effects of Aifuping tablets on symptoms and signs of monkey model of monkey immunodeficiency virus (SIV) infection: During the experiment, the general condition of monkeys after SIV infection was good, the spirit was good, and the appetite was general. The changes in lymph node size before and after treatment in each group belonged to the usual response after infection with SIV, and there was no significant difference between the groups. One monkey in the SIV control group died 80 days after infection. The autopsy was seen: submandibular, axillary and inguinal lymph nodes; subcapsular lymph node enlargement, texture became solid; left and right lobes swollen, gray-red, texture became solid; colonic mucosa congestion, edema, focal erosion. The appetite, the spirit, etc. of other animals generally have no significant difference in body weight changes.
2、 艾伏平片对猴免疫缺陷病毒 (SIV ) 感染猴模型病毒的抑制作用: SIV感染后 SIV对 照组病毒载量的波动均在一定的范围内, 符合 SIV感染的自然变化规律。 低剂量组治疗后病 毒载量下降明显, 尤其是停药后 8周时与治疗前比较下降了 1. 52 log,与 SIV对照组比较低 1. 34 log o 艾伏平高剂量组除有一只猴子意外死亡外, 其他猴子的病毒载量也都有明显下降。 治疗组在停药后没有出现病毒反跳现象。 因此可以认为, 实验结果提示了艾伏平片对 SIV感 染猴模型有明显的抑制病毒作用。  2. The inhibitory effect of Aifuping tablets on monkey immunodeficiency virus (SIV)-infected monkey model virus: The fluctuation of viral load in SIV control group after SIV infection is within a certain range, which is consistent with the natural variation of SIV infection. After the treatment in the low-dose group, the viral load decreased significantly, especially at 8 weeks after stopping the drug, and decreased by 1. 52 log compared with that before the treatment. 1. 34 log o Avoplanin high-dose group except one In addition to the accidental death of monkeys, the viral load of other monkeys also decreased significantly. The treatment group did not show a virus rebound after stopping the drug. Therefore, it can be considered that the experimental results suggest that Avovir tablets have a significant inhibitory effect on the SIV-infected monkey model.
3、 艾伏平片对猴免疫缺陷病毒 (SIV ) 感染猴模型免疫系统的保护作用: 通过猴淋巴结 活检显示, 对照组猴随着病程的延长, 其淋巴结结构逐渐转坏, 符合 SIV感染模型的自然病 理变化规律; 治疗组的高剂量组停药时检查淋巴结, 其结构略转差, 但明显好于对照组; 低 剂量组淋巴结组织结构并未随病程延长而变坏, 而是朝着稳定的方向发展。 提示艾伏平对免 疫系统有确定的保护作用, 且低剂量组的效果优于高剂量组。  3. The protective effect of Aifuping tablets on the immune system of monkey immunodeficiency virus (SIV) infected monkey model: The monkey lymph node biopsy showed that the lymph node structure of the control group gradually deteriorated with the prolongation of the disease course, which is consistent with the SIV infection model. The pathological changes of the natural pathology; the high-dose group in the treatment group was examined for lymph node examination, and its structure was slightly worse, but it was significantly better than the control group; the tissue structure of the low-dose group did not deteriorate with the disease course, but stabilized. The direction of development. It is suggested that Avopine has a certain protective effect on the immune system, and the low dose group is better than the high dose group.
实验例 2 : 艾伏平片补肾壮阳的实验研究 Q Experimental Example 2: Experimental study of Aifuping tablets for tonifying kidney and strengthening yang Q
(一) 实验药物: 同上。 (1) Experimental drugs: Ibid.
(二) 实验方法: 采用氢化可的松造成小鼠阳虚证, 给药 (0. 338g/Kg ) 4天后测体重、 体温、 10 分钟自主活动数及低温游泳存活时间。 将雄性大鼠去势造成肾虚动物模型, 给药 (B) Experimental methods: Hydrocortisone was used to induce yang deficiency syndrome in mice. After administration (0. 338g/Kg) for 4 days, body weight, body temperature, 10 minutes of autonomic activity and low temperature swimming survival time were measured. Castration of male rats into an animal model of kidney deficiency, administration
( 0. 338g/Kg) 28天后, 给予局部电刺激后记录大鼠阴茎勃起时间。 第 29天各组大鼠处死, 摘除包皮腺、 精囊腺、 前列腺及提肛肌, 称重, 计算脏器指数。 (0. 338 g/Kg) After 28 days, the penile erection time of the rats was recorded after local electrical stimulation. On the 29th day, the rats in each group were sacrificed. The foreskin gland, seminal vesicle, prostate and levator ani muscle were removed, weighed, and the organ index was calculated.
(三)实验结果:艾伏平片可抑制阳虚小鼠体重的下降, 显著升高体温, 明显增加自主活 动数, 延长低温游泳存活时间, 明显缩短去势大鼠阴茎勃起潜伏期。 提示艾伏平片具有明显 的补肾壮阳作用。  (III) Experimental results: Aifuping tablets can inhibit the decline of body weight of yang deficiency mice, significantly increase body temperature, significantly increase the number of spontaneous activities, prolong the survival time of low temperature swimming, and significantly shorten the penile erection latency of ovariectomized rats. It is suggested that Aifuping tablets have obvious functions of tonifying kidney and strengthening yang.
实验例 3: 艾伏平片促进免疫抑制小鼠免疫功能恢复的实验研究  Experimental Example 3: Experimental study on the effect of Aifuping Tablet on immune function recovery in immunosuppressed mice
(一) 实验药物: ①本发明药物, 同上, 制成干粉。 ②阳性药: 贞芪扶正颗粒 (国药准 字 Z22022497 ) 吉林通化神源药业有限公司生产。 环孢酶素 A: 瑞士诺华大药厂生产。  (1) Experimental drug: 1 The drug of the invention, as above, is made into a dry powder. 2 positive drugs: 贞芪 Fuzheng granules (national medicine Zhunzi Z22022497) Jilin Tonghua Shenyuan Pharmaceutical Co., Ltd. production. Cyclosporin A: Produced by Swiss Novartis Pharmaceuticals.
(二) 实验方法:  (2) Experimental methods:
1. 实验动物分组: 成人口服艾伏平干粉 5. 8 g, 为 0. 08319 g干粉 · kg—1 体重。 小鼠 用药的等效剂量为 0. 754 g干粉, kg—1 体重。 将小鼠用药的等效剂量做为低剂量; 等效剂量 的 2倍为中剂量; 等效剂量的 4倍为高剂量。 另设正常动物,模型动物和阳性药对照各一组。 阳性药成人用量每日 30g,为 0. 43g · kg"1 体重。 小鼠用量为其等效剂量的 2倍, 即 8 g干 粉 * kg—1 体重。 动物随机分组, 每组 12只。 1. Experimental animal group: Adult oral Avo Fu Ping dry powder 5. 8 g, is 0. 08319 g dry powder · kg - 1 body weight. The equivalent dose of the mouse is 0. 754 g dry powder, kg- 1 body weight. The equivalent dose of the mouse drug is used as the low dose; the equivalent dose is twice the medium dose; the equivalent dose is 4 times the high dose. Another set of normal animals, model animals and positive drug controls. The adult dose of positive drug is 30g per day, which is 0.43g · kg" 1 body weight. The amount of mice is twice the equivalent dose, that is, 8 g dry powder * kg - 1 body weight. Animals are randomly divided into groups of 12 animals.
2. 建立免疫抑制动物模型: 将动物于腹腔注射环孢酶素 A (正常对照组除外), 隔日注 射一次, 共注射 3次。 第 3次注射后次日开始灌胃给药, 每次 0. 5ml, 每日一次。 连续给药 2 周。 正常组与模型动物组同时灌胃蒸馏水。  2. Establishment of an animal model of immunosuppression: Animals were injected intraperitoneally with cyclosporin A (except for the normal control group) and injected once every other day for a total of 3 injections. The next day after the third injection, the administration was started by intragastric administration, 0.5 ml each time, once a day. Continuous administration for 2 weeks. The normal group and the model animal group were simultaneously administered with distilled water.
3. 淋巴细胞亚群检测: 小鼠眼睚放血, 肝素抗凝。 取 0. lml抗凝血与 CD:i、 CD4、 CD8和 CD19单克隆荧光抗体于 4Ό孵育结合 30分钟,然后在流式细胞仪上进行淋巴细胞亚群的检测。 3. Lymphocyte subsets detection: bleeding in the eyelids of mice, anticoagulation of heparin. 0. lml take anticoagulant and CD: i, CD 4, CD 8 , and CD 19 monoclonal antibody to a fluorescent binding 4Ό incubated for 30 minutes followed by lymphocyte subsets by flow cytometry.
(三)实验结果: 与模型组比较, 用药组 CD3 +、 CD T细胞水平和 CD4 +/CD8+T细胞比值有明 显提高。 提示艾伏平片对免疫功能的恢复有较好的促进作用。 (III) Experimental results: Compared with the model group, the CD 3 + , CD T cell levels and CD 4 + /CD 8 + T cell ratios were significantly improved in the drug group. It is suggested that Aifuping tablets can promote the recovery of immune function.
实验例 4: 艾伏平片的毒理学试验研究  Experimental Example 4: Toxicological study of Aifuping tablets
由于艾滋病患者需长期服药, 因而药物本身的安全性也至关重要。 发明人根据中药研究 指导原则的方法, 进行了动物急毒长毒试验。  Because AIDS patients need to take medication for a long time, the safety of the drug itself is also crucial. The inventors conducted an animal acute poisoning test based on the guidelines of the Chinese medicine research guidelines.
(一) 急性毒性试验研究资料  (1) Acute toxicity test research data
艾伏平片最大浓度为 2. 46g生药 /ml , 以最大浓度最大灌胃体积 (0. 8 ml/20g ) 给予小鼠 2次 /24h,累计给药剂量达 197g/kg,相当于临床成人用量 477倍(临床成人每天用药量 24. 78g 生药 /60 kg ) , 动物未见明显的毒副作用, 提示该药较大量剂量服用基本安全无毒。 (二) 长期毒性试验研究资料 The maximum concentration of Aifuping tablets was 2.46g crude drug/ml, and the mice were given 2 times/24h at the maximum concentration of maximum gavage volume (0.8 ml/20g). The cumulative dose was 197g/kg, which is equivalent to clinical adults. The dosage was 477 times (the clinical adult daily dose of 24.78g crude drug / 60 kg), the animal showed no obvious side effects, suggesting that the drug is safe and non-toxic in large doses. (2) Long-term toxicity test research data
以艾伏平片 24. 6g生药 /kg · d, 12. 3g生药 /kg · d, 6. 15g生药 /kg · d三个剂量连续灌 胃大鼠 6个月, 此时, 高、 中、低剂量, 分别相当于 60kg成人体重 59. 56、 29. 78、 14. 89倍。 结果给药期及恢复性观察期 (一个月) 与空白对照组比较, 大鼠一般状况、 体重增长、 主要 脏器系数、 肉眼观察均无明显差异。  With Aifuping tablets 24. 6g crude drug / kg · d, 12. 3g crude drug / kg · d, 6. 15g crude drug / kg · d three doses of continuous intragastric rats for 6 months, at this time, high, medium, The low dose is equivalent to 60.56, 29.78, 14.89 times of the 60kg adult weight. Results The administration period and the recovery observation period (one month) showed no significant difference in general condition, weight gain, main organ coefficient and macroscopic observation compared with the blank control group.
血液学指标:各组动物血液学大部分指标相互比较没有显著性差异,少数指标给药不同剂 量组与空白组比较虽有统计学意义, 但基本在正常值范围之内。  Hematological indicators: There was no significant difference in the majority of hematology indicators between the groups. The difference between the few doses of the different dose groups and the blank group was statistically significant, but it was basically within the normal range.
血液生化指标: 各组动物血液生化大部分指标相互比较没有显著性差异, 少数有差异的 指标也在恢复性观察 1个月后基本恢复正常。  Blood biochemical indicators: There was no significant difference in the blood biochemical indicators of each group. A few different indicators also returned to normal after one month of restorative observation.
镜下组织形态学观察: 大鼠心、 脾、 肾、 肾上腺、 脑、 垂体、 气管、 甲状腺、 甲状旁腺、 唾液腺、 胸腺、 食管、 大肠、 主动脉、 胰腺、 卵巢、 子宫、 睾丸、 附睾、 前列腺、 膀胱、 乳 腺、 脊髓、 骨髓(胸骨、 颈椎)、 坐骨神经、 肠系膜淋巴结巨检及镜检均无病理性改变, 而小 部分动物的肝细胞水肿, 肺见间质性炎症, 胃、 小肠粘膜炎细胞浸润, 经统计学处理后, 空 白对照组和艾伏平片各组之间没有显著性差异, 表明艾伏平片没有明显毒性作用。  Microscopic histomorphological observation: rat heart, spleen, kidney, adrenal gland, brain, pituitary, trachea, thyroid, parathyroid gland, salivary gland, thymus, esophagus, large intestine, aorta, pancreas, ovary, uterus, testis, epididymis, There were no pathological changes in the prostate, bladder, breast, spinal cord, bone marrow (sternum, cervical vertebra), sciatic nerve, mesenteric lymph node and microscopic examination, while hepatocyte edema in a small part of the animal, interstitial inflammation in the lung, stomach and small intestine mucosa Inflammatory cell infiltration, after statistical treatment, there was no significant difference between the blank control group and the Aifuping tablets, indicating that Aifuping tablets had no obvious toxic effects.
结论: 艾伏平片临床用药范围内是基本安全的。  Conclusion: Aifuping tablets are basically safe in the scope of clinical use.
实验例 5: 艾伏平片的临床治疗情况  Experimental Example 5: Clinical treatment of Aifuping tablets
1992〜1993年, 发明人先后分别使用本发明三组技术方案的中药组合物在肯尼亚用于治 疗艾滋病。 受治患者达 239例, 全部 HIV阳性, 合并有一种或几种以上的机会感染, 其中 12 例曾经过其他抗艾滋病药物治疗, 227例 (占 94. 9%) 未经其他治疗。 症状与体征中以发热、 消痩、 腹泻、 瘙痒、 咳嗽、 食欲减退、 失眠、 性欲减退、 淋巴结肿大等出现率较高。 服用本 药, 2〜3粒 /次, 2〜3次 /日, 饭后服, 用白开水送服。连服 22〜25天, 休息 6〜7天后重复。 83. 7%的患者服药天数在 99天以内,服药 200天以上者仅 14例(占 5. 9%)。治疗总有效率 97. 5%。 在服药 200天以上的患者 14例中, 病毒载量未检出者 3例, 占 21. 4%。 该结果进一步证明了 本发明中药组合物对艾滋病的治疗作用。  From 1992 to 1993, the inventors used the traditional Chinese medicine compositions of the three sets of technical solutions of the present invention to treat AIDS in Kenya. A total of 239 patients were treated, all HIV-positive, with one or more opportunistic infections, 12 of whom had been treated with other anti-AIDS drugs, and 227 (94.9%) had no other treatment. Symptoms and signs have a higher incidence of fever, phlegm, diarrhea, itching, cough, loss of appetite, insomnia, loss of libido, and swollen lymph nodes. Take this medicine, 2~3 capsules/time, 2~3 times/day, take it after meals, and take it with boiled water. Even served 22 to 25 days, rest 6 to 7 days later. 83. 7% of the patients took the drug within 99 days, and only 14 patients (accounting for 5.9%) took more than 200 days. The total effective rate of treatment was 97.5%. Of the 14 patients who took the drug for more than 200 days, 3 patients had no viral load, accounting for 21. 4%. This result further demonstrates the therapeutic effect of the traditional Chinese medicine composition of the present invention on AIDS.
多次实验证明, 下面各组实施例的中药组合物均可不同程度的实现上述实验例效果, 显 示其对艾滋病及其并发症的治疗作用, 且该药物本身无毒副作用。 具体实施方式- 实施例 1 :  A number of experiments have shown that the traditional Chinese medicine compositions of the following groups of examples can achieve the effects of the above experimental examples to varying degrees, showing their therapeutic effects on AIDS and its complications, and the drug itself has no toxic side effects. DETAILED DESCRIPTION OF THE INVENTION - Example 1
将鹿茸 30g、 淫羊藿 120g、 黄芪 120g、 蛇床子 120g、 山茱萸 120g、 熟地黄 240g—起水 煎煮两次, 每次加 10倍量水。 煎液口服, 当日服完, 连用 6个月。 病毒载量被控制到抑制水 1Q 平, 患者自感体力明显增强, 生活质量明显提高。 Decoction 30g, Epimedium 120g, Astragalus 120g, Cnidium 120g, Hawthorn 120g, Rehmannia glutinosa 240g - boiled twice, add 10 times the amount of water each time. The decoction is taken orally and served on the same day for 6 months. Viral load is controlled to inhibit water 1Q level, the patient's self-inductive physical strength is significantly enhanced, and the quality of life is significantly improved.
实施例 2:  Example 2:
将鹿茸 500g、 淫羊藿 1600g、 黄芪 1600g、 蛇床子 1600g、 山茱萸 1600g、 熟地黄 3300g 一起水煎煮两次, 每次加水 10倍量。 煎液密封包装, 恒温冷藏, 分 10天服完, 连用 5个月。 病毒载量未检出, 患者食欲正常、 .体重正常, 精神状态良好。  500g of velvet antler, 1600g of Epimedium, 1600g of Astragalus, 1600g of Cnidium, 1600g of Hawthorn, and 3300g of Rehmannia glutinosa were boiled twice, and water was added 10 times each time. The decoction is sealed and packaged, kept at a constant temperature, and served in 10 days, for 5 months. The viral load was not detected, the patient's appetite was normal, the weight was normal, and the mental state was good.
实施例 3:  Example 3:
处方: 鹿茸 50g、 淫羊藿 160g、 黄芪 120g、 蛇床子 160g、 山茱萸 120g、 熟地黄 330g。 用法: 将上述原料药一起水煎煮 2-3次, 每次加水 8- 10倍量, 煎液口服, 当时服完, 连 用 3个月以上。  Prescription: 50g of velvet antler, 160g of epimedium, 120g of astragalus, 160g of Cnidium, 120g of Hawthorn, 330g of Rehmannia glutinosa. Usage: Decoction the above raw materials together 2-3 times, add 8- 10 times of water each time, decoction orally, served at the time, for more than 3 months.
效果: 该方被应用于治疗艾滋病患者 30余例, 有效率达 92%。  Effect: The prescription was applied to treat more than 30 cases of AIDS patients, with an effective rate of 92%.
实施例 4:  Example 4:
处方: 鹿茸 40g、 淫羊藿 130g、 黄芪 130g、 蛇床子 130g、 山茱萸 130g、 熟地黄 260g。 用法: 水煎液口服。  Prescription: 40g of velvet, 130g of Epimedium, 130g of Astragalus, 130g of Cnidium, 130g of Hawthorn, 260g of Rehmannia glutinosa. Usage: Oral decoction.
实施例 5:  Example 5
处方: 鹿茸 45g、 淫羊藿 150g、 黄芪 150g、 蛇床子 150g、 山茱萸 150g、 熟地黄 300g。 用法: 水煎液口服。  Prescription: Deer antler 45g, Epimedium 150g, Astragalus 150g, Cnidium 150g, Hawthorn 150g, Rehmannia glutinosa 300g. Usage: Oral decoction.
实施例 6:  Example 6:
处方: 鹿茸 45g、 淫羊藿 150g、 黄芪 150g、 蛇床子 130g、 山茱萸 130g、 熟地黄 260g。 用法: 水煎液口服。  Prescription: Deer antler 45g, Epimedium 150g, Astragalus 150g, Cnidium 130g, Hawthorn 130g, Rehmannia 260g. Usage: Oral decoction.
实施例 7:  Example 7
处方: 鹿茸 42g、 淫羊藿 140g、 黄芪 140g、 蛇床子 140g、 山茱萸 140g、 熟地黄 280g。 用法: 水煎液口服; 或者将鹿茸打粉, 与其他原料药的水提浓缩液合并, 干燥, 粉碎, 装成胶囊。  Prescription: antler 42g, epimedium 140g, astragalus 140g, Cnidium 140g, Hawthorn 140g, Rehmannia 280g. Usage: Oral decoction; or powdered antler, combined with water extract concentrate of other APIs, dried, crushed, and packed into capsules.
效果: 该方被应用于治疗艾滋病患者 70余例, 有效率达 96%。  Effect: The side has been used to treat more than 70 cases of AIDS patients, with an effective rate of 96%.
实施例 8:  Example 8
处方:鹿茸 300g、淫羊藿 1200g、黄芪 1200g、蛇床子 1200g、山茱萸 1200g、熟地黄 2400g、 仙茅 1200g、 肉豆蔻 1200g、 山药 1200g。  Prescription: antler 300g, epimedium 1200g, astragalus 1200g, Cnidium 1200g, Hawthorn 1200g, Rehmannia glutinosa 2400g, Curculigo 1200g, Nutmeg 1200g, Yam 1200g.
工艺:  Process:
( 1 ) 取上述原料药, 将鹿茸粉碎成细粉, 备用;  (1) taking the above-mentioned raw materials, crushing the velvet antler into fine powder, and waiting for it;
( 2 ) 将肉豆蔻加足量的水加热蒸镏, 收集产生的挥发油并用 70%溶解, 备用; 蒸馏后的 水溶液及药渣另置备用; χχ (2) heating the nutmeg with a sufficient amount of water to heat the steam, collecting the volatile oil produced and dissolving it with 70%, and storing it; the distilled aqueous solution and the dregs are set aside; Χχ
(3) 将山茱萸、 仙茅、 蛇床子加足量的 70%乙醇回流提取 2次, 每次提取 1小时, 合 并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1.25〜1.30的浸膏, 浸膏和药渣 备用; (3) Add 2 times of 70% ethanol from Hawthorn, Curculigo, and Cnidium, and extract for 1 hour each time. Combine the ethanol extract, recover the ethanol, and concentrate to 60 ° C under reduced pressure. The relative density is 1.25~ 1.30 extract, extract and dregs for use;
(4) 将熟地黄、 淫羊藿、 黄芪、 山药和步骤 (2) (3) 所得药渣合并, 加足量的水煎煮 2次, 每次 1个小时, 合并水煎煮液以及步骤(2)所得水溶液, 减压浓缩至 60°C时相对密度 为 1.25〜1.30的浸膏, 备用;  (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add enough water to cook twice, each time for 1 hour, combine water decoction and steps (2) The obtained aqueous solution is concentrated under reduced pressure to an extract having a relative density of 1.25 to 1.30 at 60 ° C, and used;
(5)将步骤 (3) 与 (4) 的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉以及适量 的淀粉和糊精, 用步骤 (2) 中的挥发油乙醇溶液制粒, 干燥, 制成颗粒剂。  (5) Combine the extracts of steps (3) and (4), vacuum dry, pulverize into dry paste powder, add antler powder and appropriate amount of starch and dextrin, and granulate with the volatile oil ethanol solution in step (2). Dry and make granules.
实施例 9:  Example 9
处方:鹿茸 500g、淫羊藿 1600g、黄芪 1600g、蛇床子 1600g、山茱萸 1600g、熟地黄 3300g、 仙茅 1600g、 肉豆蔻 1600g、 山药 1600g。  Prescription: 500g of velvet antler, 1600g of Epimedium, 1600g of Astragalus, 1600g of Cnidium, 1600g of Hawthorn, 3300g of Rehmannia glutinosa, 1600g of Curculigo, 1600g of nutmeg, 1600g of Chinese yam.
工艺:  Process:
(1) 按比例取上述原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the above-mentioned raw materials in proportion, and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 7倍量水蒸馏, 收集挥发油至没有油滴产生, 将挥发油加 5倍量的倍他 环糊精研磨包合, 所得包合物干燥备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 7 times the amount of water, collecting the volatile oil until no oil droplets are produced, adding the volatile oil to the 5-fold amount of betacyclodextrin, and drying the obtained clathrate; the aqueous solution and the drug after distillation The slag is reserved for use;
(3) 将山茱萸、 仙茅、 蛇床子加 5倍量 90%乙醇回流提取 3次, 每次提取 2小时, 合 并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1.30〜1.35的浸膏, 浸膏和药渣 备用;  (3) The hawthorn, the curculigo, the cnidium and the 5 times amount of 90% ethanol were refluxed and extracted three times, each time for 2 hours, the ethanol extract was combined, the ethanol was recovered, and the relative density was 1.30~ when concentrated under reduced pressure to 60 °C. 1.35 extract, extract and dregs for use;
(4) 将熟地黄、 淫羊藿、 黄芪、 山药和步骤 (2) (3) 所得药渣合并, 加水煎煮 3次, 每次加 5倍量水, 煎煮 2个小时, 合并水煎煮液以及步骤 (2) 所得水溶液, 减压浓缩至 60 °C时相对密度为 1.30〜1.35的浸膏, 备用;  (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water to cook for 3 times, add 5 times of water each time, cook for 2 hours, combine with water to cook. The cooking liquid and the aqueous solution obtained in the step (2) are concentrated under reduced pressure to an extract having a relative density of 1.30 to 1.35 at 60 ° C, and used;
(5)将步骤(3)与(4)的浸膏合并, 减压干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2) 的倍他环糊精包合物、 1倍量的淀粉, 制粒, 再加入少量微晶纤维素, 混匀后填成胶囊剂。  (5) Combining the extracts of steps (3) and (4), drying under reduced pressure, pulverizing into a dry paste powder, adding velvet powder and the beta-cyclodextrin inclusion compound of step (2), 1 time of starch , granulation, add a small amount of microcrystalline cellulose, mix and fill into capsules.
实施例 10:  Example 10
处方:鹿茸 300g、淫羊藿 1200g、黄芪 1200g、蛇床子 1200g、山茱萸 1600g、熟地黄 3300g、 仙茅 1600g、 肉豆蔻 1600g、 山药 1200g。  Prescription: 300g of velvet antler, 1200g of epimedium, 1200g of Astragalus, 1200g of Cnidium, 1600g of Hawthorn, 3300g of Rehmannia glutinosa, 1600g of Curculigo, 1600g of nutmeg, 1200g of Chinese yam.
工艺:  Process:
(1) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use;
(2) 将肉豆蔻、 山茱萸、 仙茅、 蛇床子粉碎成粗粉, 加 80%乙醇回流提取 2次, 第 1 次加 6倍量提取 2小时, 第 2次加 5倍量提取 1.5小时, 合并乙醇提取液, 回收乙醇, 减压 浓缩至 6CTC时相对密度为 1.30〜1.32的浸膏, 浸膏和药渣备用; (3) 将熟地黄、 淫羊藿、 黄芪和山药加水煎煮 2次, 第 1次加 10倍量水煎煮 2小时, 第二次与步骤 (2) 所得药渣合并, 加 8倍量水煎煮 1.5小时, 合并水煎煮液, 减压浓缩至 6CTC时相对密度为 1.05〜1.10的清膏, 高速离心, 分取离心液, 继续减压浓缩至 6CTC时相 对密度约为 1.30〜1.32的浸膏, 备用; (2) The nutmeg, hawthorn, curculigo, and cnidium are pulverized into coarse powder, and refluxed with 80% ethanol for 2 times. The first time is added with 6 times for 2 hours, and the second time with 5 times for 1.5 hours. The ethanol extract is combined, the ethanol is recovered, and the extract having a relative density of 1.30 to 1.32 is concentrated to 6 CTC under reduced pressure, and the extract and the dregs are reserved; (3) Decoction of Rehmannia glutinosa, Epimedium, Astragalus and Chinese yam twice, the first time with 10 times the amount of water for 2 hours, the second time with the step (2) to obtain the dregs, add 8 times the amount Decoction for 1.5 hours, combined with water decoction, concentrated to 6CTC, the relative density of 1.05~1.10 clear paste, high-speed centrifugation, separate the centrate, continue to concentrate under reduced pressure to 6CTC, the relative density is about 1.30~1.32 Extract, spare;
(4) 将步骤 (2) 与 (3) 的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及糖浆、 蜂蜜等, 加热混匀, 制成膏剂。  (4) Combine the extracts of steps (2) and (3), vacuum dry, pulverize into dry paste powder, add antler powder, syrup, honey, etc., heat and mix to make a paste.
实施例 11:  Example 11
处方:鹿茸 400g、淫羊藿 1300g、黄芪 1300g、蛇床子 1300g、山茱萸 1300g、熟地黄 2600g、 仙茅 1300g、 肉豆蔻 1300g、 山药 1300g。  Prescription: 400g of velvet antler, 1300g of epimedium, 1300g of Astragalus, 1300g of Cnidium, 1300g of Hawthorn, 2600g of Rehmannia glutinosa, 1300g of Curculigo, 1300g of nutmeg, 1300g of Chinese yam.
工艺:  Process:
(1) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 8倍量水蒸馏 6小时, 收集挥发油, 并用 4倍量倍他环糊精包合 2个小 时, 所得包合物干燥后备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 8 times the amount of water for 6 hours, collecting the volatile oil, and wrapping it with 4 times the amount of cyclodextrin for 2 hours, and the obtained clathrate is dried and used; the distilled aqueous solution and the dregs are separately set. Standby
(3)将山茱萸、 仙茅、 蛇床子加 6倍量 80%乙醇回流提取 3次, 第 1次加 8倍量提取 2 小时, 第 2、 3次加 5倍量提取 1小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 6CTC时相 对密度为 1.26〜1.28的浸膏, 浸膏和药渣备用;  (3) Extracting hawthorn, curculigo, and Cnidium with 6 times 80% ethanol for 3 times, adding 8 times for the first time and extracting for 2 hours, extracting the second and third times with 5 times for 1 hour, combined with ethanol extraction. Liquid, recovered ethanol, concentrated under reduced pressure to 6CTC, the relative density of 1.26~1.28 extract, extract and dregs spare;
(4) 将熟地黄、 淫羊藿、 黄芪、 山药和步骤 (2) (3) 所得药渣合并, 加水煎煮 3次, 第 1次加 12倍量水煎煮 1.5小时, 第 2、 3次加 8倍量水煎煮 1个小时, 合并水煎煮液以及 步骤 (2) 所得水溶液, 减压浓缩至 60Ό时相对密度为 1.26〜1.28的浸膏, 备用;  (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water for 3 times, and add 1 time 12 times water for 1.5 hours, 2, 3 Add 8 times the amount of water for 1 hour, combine the water decoction liquid and the aqueous solution obtained in step (2), and concentrate to a concentration of 1.26~1.28 of the extract at 60 减压 under reduced pressure, and set aside;
(5)将步骤(3)与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2) 的倍他环糊精包合物、 适量糊精和微晶纤维素, 混均, 压制成片。  (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into dry paste powder, adding antler powder and the beta-cyclodextrin inclusion compound of step (2), appropriate amount of dextrin and crystallites Cellulose, mixed, pressed into tablets.
实施例 12:  Example 12:
处方:鹿茸 450g、淫羊藿 1500g、黄芪 1500g、蛇床子 1500g、山茱萸 1500g、熟地黄 3000g、 仙茅 1500g、 肉豆蔻 1500g、 山药 1500g。  Prescription: antler 450g, epimedium 1500g, astragalus 1500g, Cnidium 1500g, Hawthorn 1500g, Rehmannia glutinosa 3000g, Curculigo 1500g, Nutmeg 1500g, Yam 1500g.
工艺:  Process:
(1) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use;
(2) 将肉豆蔻加 5倍量水蒸镏 4小时, 收集挥发油, 用 6倍量倍他环糊精包合 4小时, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  (2) Adding 5 times of water to the nutmeg for 4 hours, collecting the volatile oil, and wrapping it with 6 times the amount of cyclodextrin for 4 hours, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved;
(3) 将山茱萸、 仙茅、 蛇床子加 8倍量 70%乙醇回流提取 2次, 每次提取 1.5小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1.30〜1.32的浸膏, 浸膏和药 渣备用; (4)将熟地黄、 淫羊藿、 黄芪、 山药加水煎煮 2次, 第一次加 10倍量水煎煮 1.5小时, 第二次将药渣与步骤(2) (3) 的药渣合并后再加 6倍量水煎煮 1小时, 合并水煎煮液以及步 骤 (2) 所得水溶液, 减压浓缩至 6CTC时相对密度为 1.30〜1.32的浸膏, 备用; (3) Adding hawthorn, curculigo, and Cnidium to 8 times 70% ethanol for 2 times, each time for 1.5 hours, combining ethanol extract, recovering ethanol, and concentrating under reduced pressure to 60 ° C, the relative density is 1.30~ 1.32 extract, extract and dregs for use; (4) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, and Yam twice, firstly add 10 times the amount of water for 1.5 hours, and the second time the dregs and the residue of step (2) (3) After the combination, add 6 times the amount of water to decoct for 1 hour, combine the water decoction liquid and the aqueous solution obtained in the step (2), and concentrate to a concentration of 1.30 to 1.32 at 6 CTC under reduced pressure, and set aside;
(5)将步骤(3)与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2) 的倍他环糊精包合物、 2倍量的淀粉, 加水制软材, 制成丸剂。  (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into a dry paste powder, adding velvet powder and the beta-cyclodextrin inclusion compound of step (2), 2 times the amount of starch, Add water to make soft materials and make pellets.
实施例 13:  Example 13
处方:鹿茸 450g、淫羊藿 1500g、黄芪 1500g、蛇床子 1500g、山茱萸 1300g、熟地黄 2600g、 仙茅.1300g、 肉豆蔻 1300g、 山药 1300g。  Prescription: antler 450g, epimedium 1500g, astragalus 1500g, Cnidium 1500g, Hawthorn 1300g, Rehmannia glutinosa 2600g, Curculigo 1300g, nutmeg 1300g, Yam 1300g.
工艺:  Process:
(1) 按比例取上述原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the above-mentioned raw materials in proportion, and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 4倍量水蒸馏, 收集挥发油至没有油滴产生, 收集挥发油, 备用; -蒸馏 后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 4 times the amount of water, collecting the volatile oil until no oil droplets are produced, collecting the volatile oil, and waiting for use; - the distilled aqueous solution and the dregs are reserved for use;
(3) 将山茱萸、 仙茅、 蛇床子加 5倍量 90%乙醇回流提取 3次, 每次提取 2小时, 合 并乙醇提取液, 回收乙醇, 减压浓缩至 60Ό时相对密度为 1.30〜1.35的浸膏, 浸膏和药渣 备用;  (3) Extracting hawthorn, curculigo, and Cnidium with 5 times 90% ethanol for 3 times, extracting each time for 2 hours, combining ethanol extract, recovering ethanol, and concentrating to 60 Ό under reduced pressure at a relative density of 1.30~1.35. Extract, extract and dregs for use;
(4) 将熟地黄、 淫羊藿、 黄芪、 山药和步骤 (2) (3) 所得药渣合并, 加水煎煮 3次, 每次加 5倍量水, 煎煮 2个小时, 合并水煎煮液以及步骤 (2) 所得水溶液, 减压浓缩至 60 °C时相对密度为 1.30〜1.35的浸膏, 备用;  (4) Combine rehmannia root, epimedium, astragalus, yam and the dregs obtained in step (2) (3), add water to cook for 3 times, add 5 times of water each time, cook for 2 hours, combine with water to cook. The cooking liquid and the aqueous solution obtained in the step (2) are concentrated under reduced pressure to an extract having a relative density of 1.30 to 1.35 at 60 ° C, and used;
(5)将步骤 (3) 与 (4) 的浸膏合并, 减压干燥, 粉碎成干膏粉, 加入 2.2倍植物油和 0.1倍蜂蜡, 加热混匀, 再加入鹿茸粉及挥发油, 混匀后压成软胶囊。  (5) Combine the extracts of steps (3) and (4), dry under reduced pressure, pulverize into dry paste powder, add 2.2 times vegetable oil and 0.1 times beeswax, heat and mix, then add antler powder and volatile oil, mix well Press into a soft capsule.
实施例 14:  Example 14
处方:鹿茸 420g、淫羊藿 1400g、黄芪 1400g、蛇床子 1400g、山茱萸 1400g、熟地黄 2800g、 仙茅 1400g、 肉豆蔻 1400g、 山药 1400g。  Prescription: velvet 420g, epimedium 1400g, Astragalus 1400g, Cnidium 1400g, Hawthorn 1400g, Rehmannia glutinosa 2800g, Curculigo 1400g, Nutmeg 1400g, Yam 1400g.
用法: 将上述原料药水煎煮 2次, 每次加水 8-10倍量。 煎液密封包装, 恒温冷藏, 分 10天服完, 连用 5个月。  Usage: Decoction the above raw material potion 2 times, add 8-10 times of water each time. The decoction is sealed and packaged, kept at a constant temperature, and served in 10 days, for 5 months.
实施例 15:  Example 15
处方: 鹿茸 3kg、 淫羊藿 12kg、 黄芪 12kg、 蛇床子 12kg、 山茱萸 12kg、 熟地黄 24kg、 仙茅 12kg、 肉豆蔻 12kg、 山药 12kg、 枸杞子 12kg、 肉苁蓉 12kg、 补骨脂 5.5kg。  Prescription: 3kg of velvet antler, 12kg of Epimedium, 12kg of Astragalus, 12kg of Cnidium, 12kg of Hawthorn, 12kg of Radix Rehmanniae, 24kg of Rehmannia glutinosa, 12kg of Curculigo, 12kg of nutmeg, 12kg of yam, 12kg of medlar, 12kg of Cistanche, and 5.5kg of psoralen.
用法: 将上述原料药水煎煮 2- 3次, 每次加水 8-10倍量。 煎液密封包装, 恒温冷藏, 分 10天服完, 连用 3个月。  Usage: Decoction the above raw materials for 2 - 3 times, add 8-10 times each time. The decoction is sealed and packaged, and it is kept at a constant temperature. It is served in 10 days and used for 3 months.
实施例 16: , , Example 16: , ,
14  14
处方: 鹿茸 5kg、 淫羊藿 16kg、 黄芪 16kg、 蛇床子 16kg、 山茱萸 16kg、 熟地黄 33kg、 仙茅 16kg、 肉豆蔻 16kg、 山药 16kg、 枸杞子 16kg、 肉苁蓉 16kg、 补骨脂 8. 5kg。  Prescription: 5kg of velvet antler, 16kg of Epimedium, 16kg of Astragalus, 16kg of Cnidium, 16kg of Hawthorn, 33kg of Rehmannia glutinosa, 16kg of C. chinensis, 16kg of nutmeg, 16kg of yam, 16kg of medlar, 16kg of Cistanche, and 8. 5kg of psoralen.
工艺:  Process:
( 1 ) 取上述原料药, 将鹿茸粉碎成细粉, 备用;  (1) taking the above-mentioned raw materials, crushing the velvet antler into fine powder, and waiting for it;
(2)将肉豆蔻加足量的水加热蒸馏, 收集产生的挥发油并用足量倍他环糊精包合, 所得 包合物干燥后备用; 蒸馏后的水溶液及药渣另置备用;  (2) heating and distilling the nutmeg with a sufficient amount of water, collecting the volatile oil produced and encapsulating it with a sufficient amount of beta-cyclodextrin, and drying the obtained clathrate; the aqueous solution and the dregs after distillation are separately set aside;
( 3) 将山茱萸、 仙茅、 蛇床子、 补骨脂加足量的 60%乙醇回流提取 2次, 每次提取 1 小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60Ό时相对密度为 1. 25〜1. 30的浸膏, 浸 膏和药渣备用;  (3) Add 2 times of 60% ethanol of Hawthorn, Curculigo, Cnidium, and psoralen, extract 1 hour each time, combine ethanol extract, recover ethanol, and concentrate to 60Ό under reduced pressure. 1. 25~1. 30 extracts, extracts and dregs for use;
(4)将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药和步骤 (2 ) ( 3)所得药渣合并, 加足量的水煎煮 2次, 每次 1个小时, 合并水煎煮液以及步骤(2 )所得水溶液, 减压浓缩至 60Ό时相对密度为 1. 25〜1. 30的浸膏, 备用;  (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add enough water to cook twice, each time for 1 hour, combined with water The immersion of the extract, and the relative density of the granules of 1. 25~1. 30, spare;
( 5)将步骤(3 )与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2 ) 的倍他环糊精包合物, 以及适量的淀粉和糊精, 60%乙醇干压制粒, 干燥, 制成颗粒剂。  (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into a dry paste powder, adding velvet powder and the beta-cyclodextrin inclusion compound of step (2), and an appropriate amount of starch and paste. Fine, 60% ethanol dry pressed pellets, dried, made into granules.
实施例 17:  Example 17
处方: 鹿茸 3kg、 淫羊藿 12kg、 黄芪 12kg、 蛇床子 12kg、 山茱萸 16kg、 熟地黄 33kg、 仙茅 16kg、 肉豆蔻 16kg、 山药 16kg、 枸杞子 12kg、 肉苁蓉 12kg、 补骨脂 5. 5kg。  Prescription: 3kg of velvet antler, 12kg of Epimedium, 12kg of Astragalus, 12kg of Cnidium, 16kg of Hawthorn, 33kg of Rehmannia glutinosa, 16kg of C. chinensis, 16kg of nutmeg, 16kg of yam, 12kg of medlar, 12kg of Cistanche, and 5kg of psoralen.
工艺:  Process:
( 1 ) 按比例取上述原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the above-mentioned raw materials in proportion, and pulverize the velvet antler into fine powder for use;
(2 )将肉豆蔻加 4倍量水蒸馏, 收集挥发油至没有油滴产生, 将挥发油加 5倍量的倍他 环糊精研磨包合, 所得包合物干燥备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 4 times the amount of water, collecting the volatile oil until no oil droplets are produced, adding the volatile oil to the 5-fold amount of betacyclodextrin, and drying the obtained clathrate; the aqueous solution and the drug after distillation The slag is reserved for use;
( 3) 将山茱萸、 仙茅、 蛇床子、 补骨脂加 5倍量 90%乙醇回流提取 3次, 每次提取 2 小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60Ό时相对密度为 1. 30〜1. 35的浸膏, 浸 膏和药渣备用;  (3) Extracting hawthorn, curculigo, Cnidium, and psoralen with 5 times 90% ethanol for 3 times, extracting each time for 2 hours, combining ethanol extract, recovering ethanol, and concentrating to 60 减压 under reduced pressure. 1. 30~1. 35 extracts, extracts and dregs for use;
(4)将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药和步骤(2 ) ( 3 )所得药渣合并, 加水煎煮 3次, 每次加 5倍量水, 煎煮 2个小时, 合并水煎煮液以及步骤 (2) 所得水溶液, 减压浓縮至 60°C时相对密度为 1. 30〜1. 35的浸膏, 备用;  (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add water for 3 times, add 5 times of water each time, and cook 2 times. The extract of the extract is used in an amount of 1. 30~1. 35 of the extract;
(5 )将步骤(3)与(4)的浸膏合并, 减压干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2 ) 的倍他环糊精包合物、 1倍量的淀粉, 制粒, 再加入少量微晶纤维素, 混匀后填成胶囊剂。  (5) Combining the extracts of steps (3) and (4), drying under reduced pressure, pulverizing into a dry paste powder, adding velvet powder and the beta-cyclodextrin inclusion compound of step (2), 1 time of starch , granulation, add a small amount of microcrystalline cellulose, mix and fill into capsules.
效果: 该方被应用于治疗艾滋病患者 80余例, 有效率达 96. 2%。  Effect: The side was used to treat more than 80 cases of AIDS patients, with an effective rate of 96.2%.
实施例 18: 处方: 鹿茸 4kg、 淫羊藿 13kg、 黄芪 13kg、 蛇床子 13kg、 山茱萸 13kg、 熟地黄 26kg、 仙茅 13kg、 肉豆蔻 13kg、 山药 13kg、 枸杞子 13kg、 肉苁蓉 13kg、 补骨脂 6. 5kg。 Example 18 The prescription: antler 4kg, epimedium 13kg, astragalus 13kg, Cnidium 13kg, hawthorn 13kg, rehmannia root 26kg, curculigo 13kg, nutmeg 13kg, yam 13kg, medlar 13kg, Cistanche 13kg, psoralen 6. 5kg.
工艺- Process -
( 1 ) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用; (1) Take the raw materials in proportion, and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 8倍量水蒸馏 6小时, 收集挥发油, 并用 4倍量倍他环糊精包合 2个小 时, 所得包合物干燥后备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 8 times the amount of water for 6 hours, collecting the volatile oil, and wrapping it with 4 times the amount of cyclodextrin for 2 hours, and the obtained clathrate is dried and used; the distilled aqueous solution and the dregs are separately set. Standby
(3) 将山茱萸、 仙茅、 蛇床子、 补骨脂加 6倍量 80%乙醇回流提取 3次, 第 1次加 8 倍量提取 2小时, 第 2、 3次加 5倍量提取 1小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60Ό时相对密度为 1. 26〜1. 28的浸膏, 浸膏和药渣备用;  (3) Extract Hawthorn, Curculigo, Cnidium, and psoralen with 6 times 80% ethanol for 3 times, add 8 times for the first time for 2 hours, and add 2 times for the second and third times for 5 hours. , the extracts of the extracts, the extracts and the dregs of the extracts;
(4)将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药和步骤 (2 ) (3)所得药渣合并, 加水煎煮 3次, 第 1次加 12倍量水煎煮 1. 5小时, 第 2、 3次加 8倍量水煎煮 1个小时, 合 并水煎煮液以及步骤 (2 ) 所得水溶液, 减压浓缩至 6CTC时相对密度为 1. 26〜1. 28的浸膏, 备用;  (4) Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the dregs obtained in step (2) (3), add water for 3 times, and add 12 times the amount of water for the first time. 5的浸浸。 The immersed in the second and third times, the second and third times, the amount of water was decocted for 1 hour, the water was added to the water and the aqueous solution was condensed to a concentration of 1.26~1. Paste
(5)将步骤(3 )与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2 ) 的倍他环糊精包合物、 适量糊精和微晶纤维素, 混均, 压制成片。  (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into dry paste powder, adding antler powder and the beta-cyclodextrin inclusion compound of step (2), appropriate amount of dextrin and crystallite Cellulose, mixed, pressed into tablets.
实施例 19:  Example 19
处方: 鹿茸 4. 5kg、 淫羊藿 15kg、 黄芪 15kg、 蛇床子 15kg、 山茱萸 15kg、 熟地黄 30kg、 仙茅 15kg、 肉豆蔻 15kg、 山药 15kg、 枸杞子 15kg、 肉苁蓉 15kg、 补骨脂 7. 5g。  Prescription: antler 4. 5kg, epimedium 15kg, astragalus 15kg, Cnidium 15kg, hawthorn 15kg, rehmannia root 30kg, curculigo 15kg, nutmeg 15kg, yam 15kg, hazelnut 15kg, Cistanche 15kg, psoralen 7. 5g .
工艺:  Process:
( 1 ) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用.;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use.
(2) 将肉豆蔻加 5倍量水蒸馏 4小时, 收集挥发油, 用 6倍量倍他环糊精包合 4小时, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 5 times the amount of water for 4 hours, collecting the volatile oil, and wrapping it with 6 times the amount of cyclodextrin for 4 hours, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved for use;
( 3)将山茱萸、 仙茅、 蛇床子、 补骨脂加 8倍量 70%乙醇回流提取 2次, 每次提取 1. 5 小时, 合并乙醇提取液, 回收乙醇, 减压浓縮至 60°C时相对密度为 1. 30〜1. 32的浸膏, 浸 膏和药渣备用;  (3) Two times of extracting hawthorn, curculigo, Cnidium, and psoralen with 8 times 70% ethanol, extracting each time for 1.5 hours, combining ethanol extract, recovering ethanol, and concentrating to 60 ° under reduced pressure. C, the relative density of 1. 30~1. 32 of the extract, extract and dregs spare;
(4) 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药加水煎煮 2次, 第一次加 10倍 量水煎煮 1. 5小时, 第二次将药渣与步骤 (2 ) ( 3 ) 的药渣合并后再加 6倍量水煎煮 1小时, 合并水煎煮液以及步骤(2)所得水溶液,减压浓缩至 60°C时相对密度为 1. 30〜1. 32的浸膏, 备用;  (4) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, and Yam twice, the first time adding 10 times the amount of water to cook for 1. 5 hours, the second time the dregs and steps (2 5〜1. The relative density of the aqueous solution is 1. 30~1. The relative density of the aqueous solution is 1. 30~1. 32 extracts, spare;
(5)将步骤(3 )与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤(2) 的倍他环糊精包合物、 2倍量的淀粉, 加水制软材, 制成丸剂。 lo (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into a dry paste powder, adding velvet powder and the beta-cyclodextrin inclusion compound of step (2), 2 times the amount of starch, Add water to make soft materials and make pellets. Lo
实施例 20:  Example 20
处方: 鹿茸 4.5kg、 淫羊藿 15kg、 黄芪 13kg、 蛇床子 13kg、 山茱萸 15kg、 熟地黄 30kg、 仙茅 15kg、 肉豆蔻 15kg、 山药 13kg、 枸杞子 13kg、 肉苁蓉 13kg、 补骨脂 6.5kg。  Prescription: antler 4.5kg, epimedium 15kg, astragalus 13kg, Cnidium 13kg, hawthorn 15kg, rehmannia root 30kg, curculigo 15kg, nutmeg 15kg, yam 13kg, medlar 13kg, Cistanche 13kg, psoralen 6.5kg.
工艺:  Process:
(1) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 6倍量水蒸馏 5小时, 收集挥发油, 所得挥发油用 6倍量的倍他环糊精 包合, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 6 times the amount of water for 5 hours, collecting the volatile oil, and the obtained volatile oil is wrapped with 6 times the amount of betacyclodextrin, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved;
(3) 将山茱萸、 仙茅、 蛇床子、 补骨脂粉碎成粗粉, 加 80%乙醇回流提取 2次, 第 1 次加 6倍量提取 2小时, 第 2次加 5倍量提取 1.5小时, 合并乙醇提取液, 回收乙醇, 减压 浓缩至 60°C时相对密度为 1.30〜1.32的浸膏, 浸膏和药渣备用;  (3) The hawthorn, curculigo, cnidium, and psoralen are pulverized into coarse powder, and extracted with 80% ethanol under reflux for 2 times, the first time is added with 6 times for 2 hours, and the second time is added with 5 times for 1.5 hours. The ethanol extract is combined, the ethanol is recovered, and the extract is concentrated to a concentration of 1.30 to 1.32 at 60 ° C under reduced pressure, and the extract and the dregs are reserved;
(4) 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子和山药加水煎煮 2次, 第 1次加 10倍 量水煎煮 2小时, 第二次与步骤(2) (3)所得药渣合并, 加 8倍量水煎煮 1.5小时, 合并水 煎煮液以及步骤 (2) 所得水溶液, 减压浓缩至 60C时相对密度为 1.05〜1.10的清膏, 高速 离心, 分取离心液, 继续减压浓缩至 60Ό时相对密度约为 1.30〜1.32的浸膏, 备用;  (4) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Radix and Chinese yam twice, first time with 10 times water for 2 hours, second time with step (2) (3) Dilute the dregs, add 8 times the amount of water to decoct for 1.5 hours, combine the decoction liquid and the aqueous solution obtained in step (2), concentrate under reduced pressure to a clear density of 1.05~1.10 at 60C, centrifuge at high speed, and separate the centrifugation solution. And continue to concentrate under reduced pressure to 60 Ό when the relative density is about 1.30~1.32 of the extract, spare;
(5)将步骤(3)与(4)的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉、 步骤(2) 的倍他环糊精包合物及糖浆、 蜂蜜等, 加热混匀, 制成膏剂。  (5) Combining the extracts of steps (3) and (4), vacuum drying, pulverizing into dry paste powder, adding antler powder, the beta-cyclodextrin inclusion compound of step (2), syrup, honey, etc., heating Mix and make a paste.
实施例 21- 处方: 鹿茸 4.2g、 淫羊藿 14kg、 黄芪 14kg、 蛇床子 14kg、 山茱萸 14kg、 熟地黄 28kg、 仙茅 14kg、 肉豆蔻 14kg、 山药 14kg、 枸杞子 14kg、 肉苁蓉 14kg、 补骨脂 7kg。  Example 21 - Prescription: antler 4.2g, epimedium 14kg, astragalus 14kg, Cnidium 14kg, hawthorn 14kg, rehmannia root 28kg, curculigo 14kg, nutmeg 14kg, yam 14kg, wolfberry 14kg, Cistanche 14kg, psoralen 7kg.
工艺:  Process:
(1) 按比例取原料药, 并将鹿茸粉碎成细粉, 备用;  (1) Take the raw materials in proportion and pulverize the velvet antler into fine powder for use;
(2)将肉豆蔻加 6倍量水蒸馏 5小时, 收集挥发油, 所得挥发油用 4倍量的倍他环糊精 在 4(TC条件下研磨 3小时包合, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  (2) Distilling the nutmeg with 6 times the amount of water for 5 hours, collecting the volatile oil, and extracting the volatile oil with 4 times the amount of betacyclodextrin for 4 hours under TC conditions, and the resulting clathrate is used; after distillation The aqueous solution and the dregs are reserved for use;
(3) 将山茱萸、 仙茅、 蛇床子、 补骨脂粉碎成粗粉, 加 80%乙醇回流提取 2次, 每次 加 6倍量,提取 1.5小时,合并乙醇提取液,回收乙醇,减压浓缩至 60°C时相对密度为 1.28〜 1.30的浸膏, 浸膏和药渣备用;  (3) pulverize hawthorn, curculigo, cnidium and psoralen into coarse powder, add 2 times with 80% ethanol, add 6 times each time, extract for 1.5 hours, combine ethanol extract, recover ethanol, decompress The extract has a relative density of 1.28~ 1.30 when concentrated to 60 ° C, and the extract and the dregs are reserved;
(4) 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子和山药加水煎煮 2次, 第 1次加 12倍 量水煎煮 1.5小时, 第二次与步骤(2) (3)所得药渣合并, 加 8倍量水煎煮 1小时, 合并水 煎煮液以及步骤 (2) 所得水溶液, 减压浓缩至 60°C时相对密度为 1.05〜1.10的清膏, 高速 离心, 分取离心液, 继续减压浓缩至 60°C时相对密度约为 1.28〜1.30的浸膏, 备用;  (4) Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Radix and Chinese yam twice, the first time with 12 times the amount of water for 1.5 hours, the second time and step (2) (3) Dilute the dregs, add 8 times the amount of water for 1 hour, combine the decoction liquid and the aqueous solution obtained in step (2), concentrate under reduced pressure to a clear density of 1.05~1.10 at 60 ° C, centrifuge at high speed, and separate. Centrifugal liquid, continue to concentrate under reduced pressure to 60 ° C, the relative density of about 1.28 ~ 1.30 of the extract, spare;
(5)将步骤 (3) 与 (4) 的浸膏合并, 真空干燥, 粉碎成千膏粉, 加入鹿茸粉、 微晶纤 γη 维素和乳糖适量, 混匀, 制粒, 干燥, 整粒, 递增加入步骤 (2) 的倍他环糊精包合物和少量 硬脂酸镁, 混匀, 压制成片。 (5) Combine the extracts of steps (3) and (4), vacuum dry, pulverize into a thousand paste powder, add antler powder, microcrystalline fiber Γη维素 and lactose amount, mix, granulate, dry, whole, add the beta- cyclodextrin inclusion compound and a small amount of magnesium stearate in step (2), mix and compress to form tablets.
效果: 该方被应用于治疗艾滋病患者 200余例, 总有效率达 97%。  Effect: The side has been used to treat more than 200 cases of AIDS patients, with a total effective rate of 97%.
实施例 22: 对实施例 21所得片剂进行质量检测  Example 22: Quality inspection of the tablets obtained in Example 21
【定性鉴别】  [Qualitative identification]
( 1 )取本品研细, 置显微镜下观察: 茸毛多碎断; 未骨化骨组织, 近无色, 具多数不规 则的块状突起物, 其间隐约可见条纹。  (1) Take the product and study it carefully, and observe under the microscope: the hair is broken; the boneless tissue is not ossified, it is nearly colorless, and there are many irregular block-like protrusions, and streaks are faintly visible.
(2) 取本品 8片, 除去薄膜衣, 研细, 加乙醇 30ml, 超声处理 30分钟, 滤过, 滤液置 水浴上蒸干, 残渣加甲醇 1ml使溶解, 作为供试品溶液。 另取 5—羟甲基糠醛对照品, 加乙 醇制成每 1ml含 0. 5mg的溶液, 作为对照品溶液。 照薄层色谱法(中国药典 2005年版一部附 录 I B)试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 GF254薄层板上, 以石油醚(60〜 90°C ) -乙酸乙酯 (1 : 1 ) 为展幵剂, 展开, 取出, 晾干, 置紫外光灯 (254皿) 下检视。 供 试品色谱中, 在与对照品色谱相应的位置上, 显相同颜色的斑点。 (2) Take 8 pieces of this product, remove the film coat, grind finely, add 30 ml of ethanol, sonicate for 30 minutes, filter, and evaporate the filtrate on a water bath. Add 1 ml of methanol to the residue to dissolve it, and use it as a test solution. 5重量的溶液。 As a reference solution, a solution of 5-hydroxymethylfurfural was added, and ethanol was added to make a solution containing 0.5 mg per 1 ml. According to the thin layer chromatography (Chinese Pharmacopoeia 2005 edition, an appendix IB) test, draw 5 μl of each of the above two solutions, respectively, on the same silica gel GF 254 thin layer plate, with petroleum ether (60 ~ 90 ° C) - Ethyl acetate (1:1) is a spreading agent, unrolled, taken out, air-dried, and placed under a UV lamp (254 dishes). In the chromatogram of the test sample, spots of the same color are displayed at positions corresponding to the chromatogram of the reference substance.
(3) 取本品 8片, 除去薄膜衣, 研细, 加乙醚 30ral , 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 残渣加乙醇 lml使溶解, 作为供试品溶液。 另取山茱萸对照药材 0. 5g, 同法制备 对照药材溶液。 照薄层色谱法(中国药典 2005年版一部附录 VI B)试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 G薄层板上, 以环己垸一二氯甲垸 -乙酸乙酯-甲酸 (20 : 5 : 8 : 0. 2)为 展开剂, 展开, 取出, 晾干, 喷以 10%硫酸溶液, 于 105Ό烘至斑点显色清晰。供试品色谱中, 在与对照药材色谱相应的位置上, 显相同颜色的斑点。  (3) Take 8 pieces of this product, remove the film coat, grind finely, add ether 30ral, heat and reflux for 20 minutes, let cool, filter, the filtrate is evaporated, and the residue is added with ethanol lml to dissolve, as the test solution. Take the Hawthorn medicinal material 0. 5g, the same method to prepare the reference drug solution. According to the thin-layer chromatography (Chinese Pharmacopoeia 2005 edition, an appendix VI B) test, take 5 μl of each of the above two solutions, respectively, on the same silica gel G thin-layer plate, with cyclohexyl-dichloromethane-acetic acid Ethyl ester-formic acid (20:5:8:0.2) was used as a developing solvent, unrolled, taken out, air-dried, sprayed with 10% sulfuric acid solution, and dried at 105 Torr until the spots were clear. In the chromatogram of the test sample, spots of the same color are displayed at positions corresponding to the chromatogram of the reference drug.
(4) 取本品 14片, 除去薄膜衣, 研细, 加甲醇 50ml, 加热回流 4小时, 过滤, 滤液蒸 干,残渣加水 20ml搅拌使溶解, 移至分液漏斗中, 以水饱和的正丁醇萃取 3次(20ml, 15ml , 15ml ), 合并正丁醇液, 用氨试液洗涤 2次, 每次 30ml, 弃去氨试液。 正丁醇液用正丁醇饱 和的水洗涤 3次, 每次 30ml, 弃去水液。 正丁醇液置水浴上蒸干, 残渣加水 10ml温热使溶 解, 放冷, 过 D- 101大孔吸附树脂柱(内径为 1. 5cm, 长 12cm), 以水 50ml洗脱, 弃去水液, 再用 30ml40%乙醇洗脱, 弃去洗脱液。 继以 50ml70%乙醇洗脱, 收集洗脱液, 蒸干, 残渣加甲 醇 2ml使溶解, 作为供试品溶液。 另取黄芪甲苷对照品, 加甲醇制成每 lml含 lmg的溶液, 作为对照品溶液。 照薄层色谱法 (中国药典 2005年版一部附录 VI B) 试验, 吸取供试品溶 液 Ιθμΐ , 对照品溶液 5μ1, 分别点于同一硅胶 G薄层板上, 以二氯甲垸-甲醇-水(13: 7: 2) 的下层溶液为展开剂, 展开, 取出, 晾干, 喷以 10%硫酸乙醇溶液, 105°C加热至斑点显色 清晰。 供试品色谱中, 在与对照品色谱相应的位置上, 在日光下显相同颜色的斑点。  (4) Take 14 pieces of this product, remove the film coat, grind finely, add 50ml of methanol, heat under reflux for 4 hours, filter, and evaporate the filtrate, add 20 ml of water to the residue to dissolve, transfer to the separatory funnel, and saturate with water. The butanol was extracted three times (20 ml, 15 ml, 15 ml), and the n-butanol solution was combined and washed twice with an ammonia test solution, 30 ml each time, and the ammonia test solution was discarded. The n-butanol solution was washed three times with saturated water of n-butanol, 30 ml each time, and the water was discarded. The n-butanol solution was evaporated to dryness on a water bath, and the residue was added with water 10 ml of warming to dissolve, and allowed to cool. The D-101 macroporous adsorption resin column (inner diameter: 1.5 cm, length 12 cm) was eluted with 50 ml of water, and water was discarded. The solution was eluted with 30 ml of 40% ethanol and the eluent was discarded. After eluting with 50 ml of 70% ethanol, the eluate was collected, evaporated to dryness, and the residue was dissolved in methanol (2 ml) to dissolve. Another reference substance of astragaloside IV was added, and methanol was added to make a solution containing 1 mg per lml as a reference solution. According to the thin-layer chromatography (Chinese Pharmacopoeia 2005 edition, an appendix VI B) test, draw the test solution Ιθμΐ, the reference solution 5μ1, respectively, on the same silica gel G thin-layer plate, with methylene chloride-methanol-water The lower layer solution of (13: 7: 2) is a developing solvent, unrolled, taken out, air-dried, sprayed with 10% sulfuric acid in ethanol, and heated at 105 ° C until the spots are clear. In the chromatogram of the test sample, spots of the same color are displayed in daylight at a position corresponding to the chromatogram of the reference substance.
(5)取蛇床子对照药材 0. 5g, 加乙醚 30ml, 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 1 Q 残渣加乙醇 lml使溶解,作为对照药材溶液。照薄层色谱法(中国药典 2005年版一部附录 VIB) 试验, 吸取鉴别(3)项下的供试品溶液及蛇床子对照药材溶液各 5 μ 1, 分别点于同一硅胶 G 薄层板上, 以甲苯 -乙酸乙酯 (30 : 1 ) 为展开剂, 展开, 取出, 晾干, 置紫外光灯 (365nm) 下检视。 供试品色谱中, 在与对照药材色谱相应的位置上, 显相同颜色的斑点。 (5) Take the Cnidium chinensis reference material 0. 5g, add ether 30ml, heat reflux for 20 minutes, let cool, filter, the filtrate is dried, 1 Q residue was added with 1 ml of ethanol to dissolve, and used as a reference drug solution. According to the thin-layer chromatography (Chinese Pharmacopoeia 2005 edition, an appendix VIB) test, the 5 μ 1 of the test solution and the Cnidium reference drug solution under the identification (3) are respectively placed on the same silica gel G thin layer plate. , using toluene-ethyl acetate (30:1) as a developing solvent, unrolling, taking out, drying, and viewing under ultraviolet light (365 nm). In the chromatogram of the test sample, spots of the same color are displayed at positions corresponding to the chromatogram of the reference drug.
(6) 取本品 8片, 除去薄膜衣, 研细, 加水 35ml, 加热煮沸 15分钟, 放冷, 滤过, 滤 液用乙酸乙酯振摇提取两次, 每次 15ml, 置水浴上蒸干, 残渣加乙酸乙酯 lml使溶解, 作为 供试品溶液。 另取枸杞子对照药材 0. 5g, 同法制备对照药材溶液。 照薄层色谱法(中国药典 2005年版一部附录 VI B)试验,吸取供试品溶液、阴性样品溶液各 10 μ 1,对照药材溶液 2 μ 1, 分别点于同一硅胶 G薄层板上, 以乙酸乙酯-二氯甲烷 -甲酸(3: 2: 1 ) 为展开剂, 展开, 取 出, 晾干, 置紫外灯 (365nm) 下检视。 供试品色谱中, 在与对照药材色谱相应的位置上, 显 相同颜色的荧光斑点。  (6) Take 8 pieces of this product, remove the film coat, grind finely, add 35ml of water, boil for 15 minutes, let cool, filter, and extract the filtrate twice with ethyl acetate, 15ml each time, steam on the water bath. The residue was added with 1 ml of ethyl acetate to dissolve, and used as a test solution. Another scorpion reference drug 0. 5g, the same method to prepare a reference drug solution. According to the thin layer chromatography (Chinese Pharmacopoeia 2005 edition of an Appendix VI B) test, draw the test solution, the negative sample solution 10 μl, the reference drug solution 2 μ 1, respectively, on the same silica gel G thin-layer plate, Ethyl acetate-dichloromethane-formic acid (3:2:1) was used as a developing solvent, developed, taken out, dried, and placed under UV light (365 nm). In the chromatogram of the test sample, fluorescent spots of the same color are displayed at positions corresponding to the chromatogram of the reference drug.
( 7) 取本品 20片, 除去薄膜衣, 研细, 按挥发油测定法(中国药典 2005年版一部附录 K D)提取挥发油, 自挥发油提取器刻度管上端加入石油醚 (30〜60°C ) lml, 蒸馏 5小时, 分取石油醚液作为供试品溶液。 另取肉豆蔻对照药材 2g, 同法制备对照药材溶液。 照薄层色 谱法(中国药典 2005年版一部附录 VI B)试验, 吸取供试品溶液及对照药材溶液 10 μ 1, 分别 点于同一硅胶 G薄层板上, 以石油醚(60〜90°C ) -甲苯 (1: 1 ) 为展开剂, 展幵, 取出, 晾 干, 喷以茴香醛试液, 于 105°C加热至斑点显色清晰。 供试品色谱中, 在与对照药材色谱相 应的位置上, 在日光下显相同颜色的斑点。  (7) Take 20 pieces of this product, remove the film coat, and grind the fine oil. According to the volatile oil determination method (Chinese Pharmacopoeia 2005 edition, an appendix KD), extract the volatile oil, and add petroleum ether (30~60 °C) from the upper end of the volatile oil extractor scale tube. Lml, distilled for 5 hours, and the petroleum ether solution was taken as the test solution. Another 2 g of the reference material of the nutmeg was prepared, and the reference medicine solution was prepared by the same method. According to the thin-layer chromatography (Chinese Pharmacopoeia 2005 edition, an appendix VI B) test, draw the test solution and the reference drug solution 10 μ 1, respectively, on the same silica gel G thin-layer plate, with petroleum ether (60~90°) C) - Toluene (1: 1) is a developing agent, spread, removed, dried, sprayed with anisaldehyde test solution, heated at 105 ° C until the spots are clear. In the chromatogram of the test sample, spots of the same color are displayed in daylight at a position corresponding to the chromatogram of the reference drug.
【含量测定】  [Content determination]
色谱条件与系统适用性试验: 用十八烷基硅垸键合硅胶为填充剂; 乙腈-水(28: 72)为 流动相; 检测波长为 270皿。 理论板数按淫羊藿苷峰计算应不低于 1500。  Chromatographic conditions and system suitability test: octadecyl silicon germanium bonded silica as a filler; acetonitrile-water (28: 72) as mobile phase; detection wavelength is 270 dishes. The number of theoretical plates should be no less than 1500 according to the peak of icariin.
对照品溶液的制备: 精密称取淫羊藿苷对照品适量, 加甲醇制成每 lml 含 0. lmg 的溶 液, 即得。  Preparation of the reference solution: Accurately weigh the appropriate amount of icariin reference substance, add methanol to make a solution containing 0.1 mg per lml, that is.
供试品溶液的制备: 取本品 20片, 除去薄膜衣, 研细, 取约 0. 5g, 精密称定, 置具塞 锥形瓶中, 精密加入稀乙醇 25ml, 称定重量, 超声处理 (功率: 240W, 频率: 45kHz) 30分 钟, 再称定重量, 用稀乙醇补足减失的重量, 摇匀, 用微孔滤膜(0. 45 μ πι)滤过, 取续滤液, 即得。  Preparation of the test solution: Take 20 pieces of this product, remove the film coat, grind finely, take about 0. 5g, accurately weighed, set in a conical flask, precision added 25ml of dilute ethanol, weighed, sonicated (power: 240W, frequency: 45kHz) 30 minutes, weigh the weight, make up the lost weight with dilute ethanol, shake well, filter with microporous membrane (0. 45 μ πι), take the filtrate, get .
测定法: 精密吸取对照品溶液与供试品溶液各 10 μ 1, 注入液相色谱仪, 测定, 即得。 结果: 本品每片含淫羊藿以淫羊藿苷 (CM 。015) 计不少于 0. 50mg。 Assay: Accurately draw 10 μl of each of the reference solution and the test solution into the liquid chromatograph and measure. Results: The product at each containing Epimedium icariin (C M .0 15) not less than 0. 50mg.

Claims

权利要求 Rights request
1、一种用于治疗艾滋病的中药组合物, 其特征在于该中药组合物的有效成分是由如下重量份 的原料药制成的:  A traditional Chinese medicine composition for treating AIDS, characterized in that the active ingredient of the traditional Chinese medicine composition is made of the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160份、 蛇床子 120〜160份、 山茱萸 120〜160份、 熟地黄 240〜330份。  Deer antler 30~50 parts, Epimedium 120~160 parts, Astragalus 120~160 parts, Cnidium 120~160 parts, Hawthorn 120~160 parts, Rehmannia glutinosa 240~330 parts.
2、 如权利要求 1所述的中药组合物, 其特征在于各原料药的组成为:  2. The traditional Chinese medicine composition according to claim 1, wherein the composition of each of the raw materials is:
鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 130〜150份、 熟地黄 260〜300份。  40~45 parts of velvet antler, 130~150 parts of Epimedium, 130~150 parts of Astragalus, 130~150 parts of Cnidium, 130~150 parts of Hawthorn, 260~300 parts of Rehmannia glutinosa.
3、 如权利要求 2所述的中药组合物, 其特征在于各原料药的组成为:  3. The traditional Chinese medicine composition according to claim 2, wherein the composition of each of the raw materials is:
鹿茸 42份、 淫羊藿 140份、黄芪 140份、蛇床子 140份、 山茱萸 140份、熟地黄 280份。 42 velvet antler, 140 epimedium, 140 radix, 140 cnidium, 140 hawthorn, and 280 rehmannia.
4、 一种用于治疗艾滋病的中药组合物, 其特征在于该中药组合物的有效成分是由如下重量份 的原料药制成的: 4. A traditional Chinese medicine composition for treating AIDS, characterized in that the active ingredient of the traditional Chinese medicine composition is made of the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160份、 蛇床子 120〜160份、 山茱萸 120〜160份、 熟地黄 240〜330份、 仙茅 120〜160份、 肉豆蔻 120〜160份、 山药 120〜160份。  30~50 parts of velvet antler, 120~160 parts of Epimedium, 120~160 parts of Astragalus, 120~160 parts of Cnidium, 120~160 parts of Hawthorn, 240~330 parts of Rehmannia glutinosa, 120~160 parts of C. chinensis, Nutmeg 120 ~160 servings, 120 to 160 copies of yam.
5、 如权利要求 4所述的中药组合物, 其特征在于各原料药的组成为- 鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 130〜150份、 熟地黄 260〜300份、 仙茅 130〜150份、 肉豆蔻 130〜150份、 山药 130〜150份。 '  The traditional Chinese medicine composition according to claim 4, wherein the composition of each of the raw materials is - 40 to 45 parts of velvet, 130 to 150 parts of Epimedium, 130 to 150 parts of Astragalus, 130 to 150 parts of Cnidium, Hawthorn 130~150 parts, Rehmannia 260~300 parts, Curculigo 130~150 parts, Nutmeg 130~150 parts, Yam 130~150 parts. '
6、 如权利要求 5所述的中药组合物, 其特征在于各原料药的组成为:  6. The traditional Chinese medicine composition according to claim 5, wherein the composition of each of the raw materials is:
鹿茸 42份、 淫羊藿 140份、黄芪 140份、蛇床子 140份、 山茱萸 140份、熟地黄 280份、 仙茅 140份、 肉豆蔻 140份、 山药 140份。  42 velvet antler, 140 epimedium, 140 radix, 140 cnidium, 140 hawthorn, 280 rehmannia, 140 condiment, 140 nutmeg, and 140 yam.
7、一种用于治疗艾滋病的中药组合物, 其特征在于该中药组合物的有效成分是由如下重量份 的原料药制成的:  7. A traditional Chinese medicine composition for treating AIDS, characterized in that the active ingredient of the traditional Chinese medicine composition is made of the following raw materials by weight:
鹿茸 30〜50份、 淫羊藿 120〜160份、 黄芪 120〜160份、 蛇床子 120〜160份、 山茱萸 120〜160份、 熟地黄 240〜330份、 仙茅 120〜160份、 肉豆蔻 120〜160份、 山药 120〜160份、 枸杞子 120〜160份、 肉苁蓉 120〜160份、 补骨脂 55〜85份。 30~50 parts of velvet antler, 120~160 parts of Epimedium, 120~160 parts of Astragalus, 120~160 parts of Cnidium, 120~160 parts of Hawthorn, 240~330 parts of Rehmannia glutinosa, 120~160 parts of C. chinensis, Nutmeg 120 ~160 parts, 120~160 parts of yam, 120~160 parts of medlar, 120~160 parts of Cistanche, and 55~85 parts of psoralen.
8、 如权利要求 7所述的中药组合物, 其特征在于各原料药的组成为: 8. The traditional Chinese medicine composition according to claim 7, wherein the composition of each of the drug substances is:
鹿茸 40〜45份、 淫羊藿 130〜150份、 黄芪 130〜150份、 蛇床子 130〜150份、 山茱萸 130〜150份、 熟地黄 260〜300份、 仙茅 130〜150份、 肉豆蔻 130〜150份、 山药 130〜150份、 枸杞子 130〜150份、 肉苁蓉 130〜150份、 补骨脂 65〜75份。 40~45 parts of velvet antler, 130~150 parts of Epimedium, 130~150 parts of Astragalus, 130~150 parts of Cnidium, 130~150 parts of Hawthorn, 260~300 parts of Rehmannia glutinosa, 130~150 parts of C. chinensis, Nutmeg 130 ~150 parts, 130~150 parts of yam, 130~150 parts of medlar, 130~150 parts of Cistanche, and 65~75 parts of psoralen.
9、 如权利要求 8所述的中药组合物, 其特征在于各原料药的配比为: 9. The traditional Chinese medicine composition according to claim 8, wherein the ratio of each raw material medicine is:
鹿茸 42份、 淫羊藿 140份、黄芪 140份、蛇床子 140份、 山茱萸 140份、熟地黄 280份、 仙茅 140份、 肉豆蔻 140份、 山药 140份、 枸杞子 140份、 肉欢蓉 140份、 补骨脂 70份。 42 antler, 140 yam, 140 radix, 140 cnidium, 140 hawthorn, 280 rehmannia, 140 cichlids, 140 nutmeg, 140 yam, 140 hazelnuts, meat scent 140 parts, 70 parts of psoralen.
10、 权利要求 7至 9中任一项所述的中药组合物的制备方法, 其特征在于该方法包括如下工 艺步骤: The method of preparing a traditional Chinese medicine composition according to any one of claims 7 to 9, characterized in that the method comprises the following process steps:
A、 取原料药, 将鹿茸粉碎成细粉, 备用;  A. Take the raw material medicine, crush the velvet antler into fine powder, and set aside;
B、 将肉豆蔻加水蒸馏, 收集挥发油并用足量倍他环糊精包合, 所得包合物备用; 蒸馏后 的水溶液及药渣另置备用;  B. Distilling the nutmeg with water, collecting the volatile oil and encapsulating it with a sufficient amount of cyclodextrin, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved for use;
C将山茱萸、仙茅、蛇床子、补骨脂加 60 %〜90 %乙醇回流提取 2〜3次, 每次提取 1〜 2小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60Ό时相对密度为 1. 25〜1. 35的浸膏, 浸 膏和药渣备用;  C. Hawthorn, Curculigo, Cnidium, psoralen and 60%~90% ethanol are refluxed for 2~3 times, each time for 1~2 hours, combined with ethanol extract, ethanol is recovered, and concentrated under reduced pressure to 60 Ό. The extract having a density of 1. 25~1. 35, the extract and the dregs are reserved;
D、 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子、 山药和步骤 B、 C所得药渣合并, 加水 煎煮 2〜3次, 每次 1〜2个小时, 合并水煎煮液以及步骤 B所得水溶液, 减压浓缩至 60°C时 相对密度为 1. 25〜1. 35的浸膏, 备用;  D. Combine Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia, Yam and the slag obtained in steps B and C, add water to decoct 2~3 times, each time for 1~2 hours, combine water decoction and The extract of the extract in the step B, the relative density of 1. 25~1. 35, the standby;
E、 将步骤 C与 D的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉及步骤 B的倍他环 糊精包合物, 制成所需剂型。  E. Combine the extracts of steps C and D, vacuum dry, pulverize into dry paste powder, add velvet powder and the beta-cyclodextrin inclusion compound of step B to prepare the desired dosage form.
11、 如权利要求 10所述的中药组合物制备方法, 其特征在于该方法包括如下工艺步骤: 11. The method of preparing a traditional Chinese medicine composition according to claim 10, characterized in that the method comprises the following process steps:
A、 取原料药, 将鹿茸粉碎成细粉, 备用; A. Take the raw material medicine, crush the velvet antler into fine powder, and set aside;
B、将肉豆蔻加 6倍量水蒸馏 5小时, 收集挥发油, 所得挥发油用 6倍量的倍他环糊精包 合, 所得包合物备用; 蒸馏后的水溶液及药渣另置备用;  B. Distilling the nutmeg with 6 times the amount of water for 5 hours, collecting the volatile oil, and the obtained volatile oil is wrapped with 6 times the amount of betacyclodextrin, and the obtained clathrate is reserved; the distilled aqueous solution and the dregs are reserved for use;
C、将山茱萸、仙茅、蛇床子、补骨脂粉碎成粗粉,加 80 %乙醇回流提取 2次,每次加 5〜 6倍量, 提取 1. 5〜2小时, 合并乙醇提取液, 回收乙醇, 减压浓缩至 60°C时相对密度为 1. 30 的浸膏, 浸膏和药渣备用;  C, the extract of hawthorn, curculigo, Cnidium, psoralen into a coarse powder, adding 80% ethanol reflux extraction 2 times, each time adding 5 to 6 times the amount, extracting 1. 5~2 hours, combined with ethanol extract, The ethanol is recovered, and the extract having a relative density of 1.30 is concentrated at 60 ° C under reduced pressure, and the extract and the dregs are reserved;
D、 将熟地黄、 淫羊藿、 黄芪、 肉苁蓉、 枸杞子和山药加水煎煮 2次, 第 1次加 10倍量 水煎煮 2小时, 第二次与步骤 B、 C所得药渣合并, 加 8倍量水煎煮 1. 5小时, 合并水煎煮液 以及步骤 B所得水溶液, 减压浓缩至 60°C时相对密度为 1. 05〜1. 10的清膏, 高速离心, 分 取离心液, 继续减压浓缩至 60°C时相对密度约为 1. 30的浸膏, 备用;  D. Decoction of Rehmannia glutinosa, Epimedium, Astragalus, Cistanche, Gardenia and Chinese yam twice, the first time with 10 times the amount of water for 2 hours, the second time with the steps B, C obtained dregs, 5的清膏, high-speed centrifugation, fractionation, with a water-repellent solution, and a solution of the aqueous solution of the step B, and concentrated to a concentration of 1. 05~1. The extract is further concentrated under reduced pressure to 60 ° C, and the relative density is about 1.30.
E、 将步骤 C与 D的浸膏合并, 真空干燥, 粉碎成干膏粉, 加入鹿茸粉、 步骤 B的倍他环 糊精包合物及制剂所需辅料, 压制成片剂。  E. Combine the extracts of steps C and D, vacuum dry, pulverize into dry paste powder, add antler powder, the beta-cyclodextrin inclusion compound of step B and the auxiliary materials required for preparation, and compress into tablets.
12、 权利要求 7至 9中任一项所述中药组合物的有效成分检测方法, 该方法含有定性鉴别和 含量测定内容, 其特征在于其中的含量测定方法为: 液相色谱条件: 用十八烷基硅垸键合硅胶为填充剂; 体积比为 28: 72的乙腈-水混合液 为流动相; 检测波长为 270皿; 理论板数按淫羊藿苷峰计算应不低于 1500; The method for detecting an active ingredient of a traditional Chinese medicine composition according to any one of claims 7 to 9, which comprises qualitative identification and content determination, wherein the content determination method is: Liquid chromatography conditions: octadecylsilicone bonded silica gel as a filler; acetonitrile-water mixture with a volume ratio of 28:72 as mobile phase; detection wavelength of 270 dishes; theoretical plate number according to icariin peak The calculation should be no less than 1500;
对照品溶液的制备: 精密称取淫羊藿苷对照品, 加甲醇制成每 1ml 含 0. lmg 的溶液, 即得;  Preparation of the reference solution: accurately weigh the icariin reference substance, add methanol to make a solution containing 0.1 mg per 1 ml, that is;
供试品溶液的制备: 取中药组合物 0. 3g〜0. 5g, 精密称定, 置具塞锥形瓶中, 精密加入 稀乙醇 25ml, 称定重量, 超声处理 30分钟, 再称定重量, 用稀乙醇补足减失的重量, 摇匀, 用 0. 45 μ πι的微孔滤膜滤过, 取续滤液, 即得;  Preparation of the test solution: Take the traditional Chinese medicine composition 0. 3g~0. 5g, accurately weighed, placed in a conical flask, precision added 25ml of diluted ethanol, weighed, sonicated for 30 minutes, then weighed The weight of the lost weight is made up with dilute ethanol, shaken, filtered through a microporous membrane of 0. 45 μ πι, and the filtrate is taken, that is, obtained;
测定法: 精密吸取对照品溶液与供试品溶液各 10 μ 1, 注入液相色谱仪, 测定, 计算数 据, 即得。  Assay: Accurately draw 10 μl of each of the reference solution and the test solution into the liquid chromatograph, measure and calculate the data.
13、如权利要求 12所述的中药组合物的有效成分检测方法, 其特征在于其中的定性鉴别方法 包括如下内容:  The method for detecting an active ingredient of a traditional Chinese medicine composition according to claim 12, wherein the qualitative identification method comprises the following contents:
Α、 取中药组合物少量, 研细, 置显微镜下观察, 可见: 茸毛多碎断; 未骨化骨组织, 近 无色, 具多数不规则的块状突起物, 其间隐约可见条纹;  Α, take a small amount of traditional Chinese medicine composition, grind finely, and observe under the microscope, it can be seen that: the hair is broken and broken; the non-ossified bone tissue, nearly colorless, with most irregular block-like protrusions, with streaks visible in the gap;
Β、 取中药组合物少量, 研细, 加乙醇 30ml , 超声处理 30分钟, 滤过, 滤液置 K浴上蒸 干, 残渣加甲醇 1ml使溶解, 作为供试品溶液; 另取 5—羟甲基糠醛对照品, 加乙醇制成每 lml含 0. 5mg的溶液, 作为对照品溶液; 照中国药典薄层色谱法试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 GF254薄层板上, 以体积比为 1 : 1的石油醚-乙酸乙酯混合液为展开 剂, 展开, 取出, 晾干, 置 254nm紫外光灯下检视; 供试品色谱中, 在与对照品色谱相应的 位置上, 显相同颜色的斑点; ·  Β, take a small amount of traditional Chinese medicine composition, grind finely, add 30ml of ethanol, sonicate for 30 minutes, filter, leave the filtrate on the K bath and evaporate dry, add 1ml of methanol to dissolve the residue, as a test solution; take 5-hydroxyl Based on the furfural reference substance, add ethanol to make a solution containing 0.5 mg per lml, as a reference solution; according to the Chinese Pharmacopoeia thin layer chromatography test, take 5 μl of each of the above two solutions, respectively, on the same silica gel GF254 thin layer On the plate, a petroleum ether-ethyl acetate mixture with a volume ratio of 1:1 is used as a developing solvent, unrolled, taken out, dried, and placed under a UV light of 254 nm; in the chromatogram of the test product, corresponding to the chromatogram of the reference substance On the position, the spots of the same color;
C、 取中药组合物少量, 研细, 加乙醚 30ml, 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 残渣加乙醇 lml使溶解, 作为供试品溶液; 另取山茱萸对照药材 0. 5g, 同法制备对照药材溶 液; 照中国药典薄层色谱法试验, 吸取上述两种溶液各 5 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 20 : 5 : 8 : 0. 2的环己烷一二氯甲垸-乙酸乙酯-甲酸混合液为展开剂, 展开, 取出, 晾干, 喷以 10%硫酸溶液, 于 105°C烘至斑点显色清晰; 供试品色谱中, 在与对照药材色谱相 应的位置上, 显相同颜色的斑点;  C. Take a small amount of traditional Chinese medicine composition, grind finely, add 30ml of ether, heat and reflux for 20 minutes, let cool, filter, the filtrate is evaporated, and the residue is added with 1ml of ethanol to dissolve, as the test solution; 5g, the same method to prepare the reference drug solution; according to the Chinese Pharmacopoeia thin-layer chromatography test, the above two solutions are taken 5 μ 1, each point on the same silica gel G thin-layer plate, the volume ratio is 20 : 5 : 8 : 0 2 cyclohexane-dichloroformamidine-ethyl acetate-formic acid mixture is used as a developing solvent, unrolled, taken out, air-dried, sprayed with 10% sulfuric acid solution, and dried at 105 ° C until the spot color is clear; In the chromatogram of the product, a spot of the same color is displayed at a position corresponding to the chromatogram of the reference drug;
D、 取中药组合物少量, 研细, 加甲醇 50ml, 加热回流 4小时, 过滤, 滤液蒸干, 残渣 加水 20ml搅拌使溶解, 移至分液漏斗中, 分别以 20ml、 15ml , 15ml的水饱和的正丁醇萃取 1次, 合并正丁醇液, 用氨试液洗涤 2次, 每次 30ml, 弃去氨试液; 正丁醇液用正丁醇饱和 的水洗涤 3次, 每次 30ml, 弃去水液; 正丁醇液置水浴上蒸干, 残渣加水 lOral温热使溶解, 放冷, 过 D-101大孔吸附树脂柱, 以水 50ml洗脱, 弃去水液, 再用 30ml的 40%乙醇洗脱, 弃去洗脱液; 继以 50ml的 70%乙醇洗脱,.收集洗脱液, 蒸干, 残渣加甲醇 2ml使溶解, 作为 供试品溶液; 另取黄芪甲苷对照品, 加甲醇制成每 lml含 lrag的溶液, 作为对照品溶液; 照 中国药典薄层色谱法试验, 吸取供试品溶液 Ιθμΐ , 对照品溶液 5μ1, 分别点于同一硅胶 G薄 层板上, 以体积比为 13: 7: 2的二氯甲垸-甲醇 -水的混合液为展开剂, 展开, 取出, 晾干, 喷以 10 %硫酸乙醇溶液, 105°C加热至斑点显色清晰; 供试品色谱中, 在与对照品色谱相应 的位置上, 在日光下显相同颜色的斑点; D. Take a small amount of traditional Chinese medicine composition, grind finely, add 50ml of methanol, heat under reflux for 4 hours, filter, and evaporate the filtrate. Add 20 ml of water to the residue to dissolve. Transfer to a separatory funnel and saturate with 20 ml, 15 ml, 15 ml of water respectively. The n-butanol was extracted once, and the n-butanol solution was combined, washed twice with ammonia test solution, 30 ml each time, and the ammonia test solution was discarded; n-butanol solution was washed 3 times with water saturated with n-butanol, 30 ml each time. , discard the water solution; n-butanol solution is evaporated to dryness in a water bath, the residue is added with water lOral warm to dissolve, let cool, pass the D-101 macroporous adsorption resin column, elute with 50ml of water, discard the water, and then use 30 ml of 40% ethanol was eluted, and the eluate was discarded. After elution with 50 ml of 70% ethanol, the eluate was collected, evaporated to dryness, and the residue was dissolved in methanol (2 ml) to dissolve. For the test solution; take the astragaloside reference substance, add methanol to make lrag solution per lml, as a reference solution; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution Ιθμΐ, the reference solution 5μ1, Place on the same silica gel G thin-layer plate, and use a mixture of dichloromethane-methanol-water in a volume ratio of 13:7:2 as a developing solvent, unroll, take out, dry, and spray with 10% sulfuric acid ethanol solution. , heating at 105 ° C until the spots are clear; in the chromatogram of the test sample, the spots of the same color are displayed in the sunlight at the position corresponding to the chromatogram of the reference substance;
Ε、 取蛇床子对照药材 0. 5g, 加乙醚 30ml, 加热回流 20分钟, 放冷, 滤过, 滤液挥干, 残渣加乙醇 1ml使溶解, 作为对照药材溶液; 照中国药典薄层色谱法试验, 吸取 C项下的供 试品溶液及蛇床子对照药材溶液各 5 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 30 : 1 的甲苯-乙酸乙酯混合液为展开剂, 展开, 取出, 晾干, 置 365mn紫外光灯下检视; 供试品色 谱中, 在与对照药材色谱相应的位置上, 显相同颜色的斑点;  Ε, take the Cnidium medicinal material 0. 5g, add ether 30ml, heat reflux for 20 minutes, let cool, filter, the filtrate is evaporated, the residue is added with ethanol 1ml to dissolve, as a reference drug solution; according to Chinese Pharmacopoeia thin layer chromatography test 5 μl of each of the test solution and the Cnidium reference drug solution under C are dispensed on the same silica gel G thin layer plate, and the toluene-ethyl acetate mixture with a volume ratio of 30:1 is used as a developing solvent. , unfold, remove, dry, and set under the 365mn ultraviolet light; in the chromatogram of the test sample, the spot of the same color is displayed at the position corresponding to the chromatogram of the reference drug;
F、 取中药组合物少量, 研细, 加水 35ml , 加热煮沸 15分钟, 放冷, 滤过, 滤液用乙酸 乙酯振摇提取两次, 每次 15ml, 置水浴上蒸干, 残渣加乙酸乙酯 lml使溶解, 作为供试品溶 液; 另取枸杞子对照药材 0. 5g, 同法制备对照药材溶液; 照中国药典薄层色谱法试验, 吸取 供试品溶液、 阴性样品溶液各 10 μ 1, 对照药材溶液 2 μ 1, 分别点于同一硅胶 G薄层板上, 以体积比为 3: 2: 1的乙酸乙酯-二氯甲烷-甲酸混合液为展开剂,展开,取出,晾干,置 365皿 紫外灯下检视; 供试品色谱中, 在与对照药材色谱相应的位置上, 显相同颜色的荧光斑点; F, take a small amount of traditional Chinese medicine composition, grind finely, add water 35ml, heat and boil for 15 minutes, let cool, filter, the filtrate is extracted twice with ethyl acetate, 15ml each time, steamed on a water bath, residue added with acetic acid The ester lml is dissolved, as a test solution; another scorpion reference drug 0. 5g, the same method to prepare a reference drug solution; according to the Chinese Pharmacopoeia thin layer chromatography test, the test solution, the negative sample solution each 10 μ 1 2 μ 1 of the reference drug solution was spotted on the same silica gel G thin layer plate, and the mixture of ethyl acetate-dichloromethane-formic acid in a volume ratio of 3:2:1 was used as a developing solvent, unrolled, taken out, and dried. , set the 365 dish under the UV lamp; in the chromatogram of the test sample, the fluorescent spot of the same color is displayed at the position corresponding to the chromatogram of the reference drug;
G、 取中药组合物少量, 研细, 按 2005年版中国药典规定的挥发油测定法提取挥发油, 自挥发油提取器刻度管上端加入沸程为 30〜60°C的石油醚 lml , 蒸馏 5小时, 分取石油醚液 作为供试品溶液; 另取肉豆蔻对照药材 2g, 同法制备对照药材溶液; 照中国药典薄层色谱法 试验,吸取供试品溶液及对照药材溶液 10 μ 1 ,分别点于同一硅胶 G薄层板上, 以体积比为 1 : 1的石油醚-甲苯为展开剂, 展幵, 取出, 晾干, 喷以茴香醛试液, 于 105°C加热至斑点显色 清晰; 供试品色谱中, 在与对照药材色谱相应的位置上, 在日光下显相同颜色的斑点。 G. Take a small amount of traditional Chinese medicine composition, and grind it. Extract the volatile oil according to the volatile oil method specified in the 2005 Chinese Pharmacopoeia. Add 1 ml of petroleum ether with a boiling range of 30~60 °C from the upper end of the scale tube of the volatile oil extractor, and distill for 5 hours. Take petroleum ether liquid as the test solution; take 2g of reference material of the nutmeg, and prepare the reference medicine solution by the same method; according to the Chinese Pharmacopoeia thin layer chromatography test, draw the test solution and the reference drug solution 10 μ 1 , respectively On the same silica gel G thin-layer plate, with a volume ratio of 1:1 petroleum ether-toluene as a developing agent, spread, take out, dry, spray with anisaldehyde test solution, and heat at 105 ° C until the spots are clear; In the chromatogram of the test sample, spots of the same color are displayed in daylight at a position corresponding to the chromatogram of the reference drug.
14、 权利要求 1至 9中任一项所述中药组合物在制备用于治疗艾滋病的药物中的应用。  14. Use of a traditional Chinese medicine composition according to any one of claims 1 to 9 for the preparation of a medicament for the treatment of AIDS.
15、 权利要求 1至 9中任一项所述中药组合物在制备用于温补肾阳的药物中的应用。  15. Use of a traditional Chinese medicine composition according to any one of claims 1 to 9 for the preparation of a medicament for warming kidney yang.
PCT/CN2010/001968 2010-03-17 2010-12-06 Pharmaceutical composition for treating aids and preparation method thereof WO2011113190A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201010125895.3 2010-03-17
CN2010101258953A CN102188537B (en) 2010-03-17 2010-03-17 Chinese medicine composition against AIDS and preparation method thereof

Publications (1)

Publication Number Publication Date
WO2011113190A1 true WO2011113190A1 (en) 2011-09-22

Family

ID=44597972

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/001968 WO2011113190A1 (en) 2010-03-17 2010-12-06 Pharmaceutical composition for treating aids and preparation method thereof

Country Status (2)

Country Link
CN (1) CN102188537B (en)
WO (1) WO2011113190A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108226313A (en) * 2016-12-15 2018-06-29 上海医药工业研究院 In glutinous rehmannia while methods of glycosides measure and fingerprint map construction method
CN108956811A (en) * 2018-06-12 2018-12-07 江苏颐海药业有限责任公司 One kind being used for the method for quality control of " invigorating heart dredging collateral oral solution " preparation
CN109085257A (en) * 2018-07-05 2018-12-25 中央民族大学 A kind of method that simultaneous quantitative detects Astragaloside IV-IV, cycloastragenol in mice plasma
CN113281439A (en) * 2021-07-25 2021-08-20 江西汇仁药业股份有限公司 Quality control detection method of Shenbao tablets

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102552437B (en) * 2012-01-16 2013-12-11 李泽琳 Chinese medicinal composition for treating acquired immune deficiency syndrome and preparation method thereof
CN103033588A (en) * 2013-01-01 2013-04-10 吉林紫鑫药业股份有限公司 Comprehensive detection method for cynomorium kidney tonifying capsule
CN103353504A (en) * 2013-06-25 2013-10-16 辽宁中医药大学 Method for identifying raw rhizoma atractylodis and rhizoma atractylodis stir-fried with bran via thin-layer chromatography
CN109541044A (en) * 2017-09-22 2019-03-29 广州白云山中药业有限公司 The quality determining method of glutinous rehmannia medicinal material
CN108815494A (en) * 2018-09-04 2018-11-16 瑞福祥药业(广西)有限公司 It is a kind of for treating the Chinese medicine composition of AIDS

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165692A (en) * 1997-04-19 1997-11-26 缪兴财 Ginseng and pilose antler pills for strengthening kidney
CN101417049A (en) * 2008-11-28 2009-04-29 段颖哲 Anti-AIDS traditional Chinese medicine compound composite and preparation method thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1286103A (en) * 2000-09-19 2001-03-07 段荣书 Medicine for treating AIDS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1165692A (en) * 1997-04-19 1997-11-26 缪兴财 Ginseng and pilose antler pills for strengthening kidney
CN101417049A (en) * 2008-11-28 2009-04-29 段颖哲 Anti-AIDS traditional Chinese medicine compound composite and preparation method thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108226313A (en) * 2016-12-15 2018-06-29 上海医药工业研究院 In glutinous rehmannia while methods of glycosides measure and fingerprint map construction method
CN108226313B (en) * 2016-12-15 2021-07-30 上海医药工业研究院 Method for simultaneous determination of glycoside components in rehmannia glutinosa Libosch and construction of fingerprint
CN108956811A (en) * 2018-06-12 2018-12-07 江苏颐海药业有限责任公司 One kind being used for the method for quality control of " invigorating heart dredging collateral oral solution " preparation
CN109085257A (en) * 2018-07-05 2018-12-25 中央民族大学 A kind of method that simultaneous quantitative detects Astragaloside IV-IV, cycloastragenol in mice plasma
CN109085257B (en) * 2018-07-05 2021-04-06 中央民族大学 Method for simultaneously and quantitatively detecting astragaloside IV and cycloastragenol in mouse plasma
CN113281439A (en) * 2021-07-25 2021-08-20 江西汇仁药业股份有限公司 Quality control detection method of Shenbao tablets

Also Published As

Publication number Publication date
CN102188537B (en) 2013-03-13
CN102188537A (en) 2011-09-21

Similar Documents

Publication Publication Date Title
WO2011113190A1 (en) Pharmaceutical composition for treating aids and preparation method thereof
Yang et al. Radix Bupleuri: a review of traditional uses, botany, phytochemistry, pharmacology, and toxicology
CA2589994C (en) A pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof
MXPA03003446A (en) Novel medicinal herbal composition for treating liver diseases and hiv.
Ling et al. Recent advance in studies on Angelica sinensis
WO2009117953A1 (en) Pharmaceutical composition having antidepressive, antianxious action and preparation method thereof
CN101721488B (en) Pharmaceutical composition for treating liver diseases and prepration method thereof
CN101002906A (en) Compounding traditional Chinese medicine, and its use
WO2010135858A1 (en) Pharmaceutical composition and use for preparing medicament thereof
CN102078543B (en) Traditional Chinese medicine preparation for treating gout and preparation method thereof
CN103223069A (en) Traditional Chinese medicine composition for treating hepatitis
CN100415255C (en) Composition of Chinese traditional medicine, and preparation method
CN101020027B (en) Medicine composition for preventing and treating AIDS and its preparation process and use
WO2013155995A1 (en) Red yeast and kudzu root pharmaceutical composition for regulating blood lipids and preparation method therefor
CN1887324B (en) Chinese medicine composition for treating liver and kidney defect, and its preparation process and analysis method
CN101912594A (en) Traditional Chinese medicine preparation for treating gastrointestinal diseases
CN109224038B (en) Traditional Chinese medicine composition containing channel-inducing medicine evodia rutaecarpa for treating blood stasis collateral blocking type hepatic fibrosis and preparation method and application thereof
CN102526305A (en) Chinese medicinal capsules for treating prostatitis and prostatic hyperplasia and preparation method for Chinese medicinal capsules
CN104095912B (en) Treat the preparation method of the Chinese patent drug of rheumatism bone disease
CN106344885B (en) Pharmaceutical composition for treating non-alcoholic fatty liver disease and preparation method and application thereof
CN104547026A (en) Preparation method and application of salvia miltiorrhiza leave and panax pseudo-ginseng extract
CN104069312B (en) Treat Chinese medicine composition of apoplexy and preparation method thereof, pharmaceutical preparation and application
CN102138965B (en) Halenia elliptica D.Don extract and preparation method, pharmaceutical composition and application thereof
CN108498761B (en) Food, health-care product or pharmaceutical composition for treating yang jaundice and preparation method and application thereof
CN105381362A (en) Composition for preventing and treating alcoholic liver injury and relieving alcoholism

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10847659

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10847659

Country of ref document: EP

Kind code of ref document: A1